JPS624118B2 - - Google Patents
Info
- Publication number
- JPS624118B2 JPS624118B2 JP53052154A JP5215478A JPS624118B2 JP S624118 B2 JPS624118 B2 JP S624118B2 JP 53052154 A JP53052154 A JP 53052154A JP 5215478 A JP5215478 A JP 5215478A JP S624118 B2 JPS624118 B2 JP S624118B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- caffeic acid
- item
- oxgol
- phenol oxidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 62
- 239000002609 medium Substances 0.000 claims description 52
- 241000221204 Cryptococcus neoformans Species 0.000 claims description 43
- 241000222122 Candida albicans Species 0.000 claims description 41
- 201000007336 Cryptococcosis Diseases 0.000 claims description 38
- 239000001963 growth medium Substances 0.000 claims description 38
- 229930182490 saponin Natural products 0.000 claims description 34
- 150000007949 saponins Chemical class 0.000 claims description 34
- 229940074360 caffeic acid Drugs 0.000 claims description 32
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 31
- 235000004883 caffeic acid Nutrition 0.000 claims description 31
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 31
- 229940095731 candida albicans Drugs 0.000 claims description 27
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 25
- 102000003425 Tyrosinase Human genes 0.000 claims description 24
- 108060008724 Tyrosinase Proteins 0.000 claims description 24
- 230000002538 fungal effect Effects 0.000 claims description 22
- 241000233866 Fungi Species 0.000 claims description 19
- 229920001817 Agar Polymers 0.000 claims description 18
- 239000008272 agar Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 15
- 230000012010 growth Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 241001337994 Cryptococcus <scale insect> Species 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 238000007747 plating Methods 0.000 claims description 10
- 210000001124 body fluid Anatomy 0.000 claims description 8
- 239000010839 body fluid Substances 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 6
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 claims description 4
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 claims description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims description 2
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 claims description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 2
- MAEVSPLUELJOMM-UHFFFAOYSA-N caffeic acid methyl ester Natural products COC(=O)C=CC1=CC=C(O)C=C1O MAEVSPLUELJOMM-UHFFFAOYSA-N 0.000 claims description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 claims description 2
- 229960004502 levodopa Drugs 0.000 claims description 2
- 229960002748 norepinephrine Drugs 0.000 claims description 2
- 229940118683 ox bile extract Drugs 0.000 claims description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 claims description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims 2
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 claims 1
- OCNYGKNIVPVPPX-HWKANZROSA-N methyl caffeate Chemical compound COC(=O)\C=C\C1=CC=C(O)C(O)=C1 OCNYGKNIVPVPPX-HWKANZROSA-N 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 description 27
- 238000012360 testing method Methods 0.000 description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 11
- 238000004362 fungal culture Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 11
- 229920000053 polysorbate 80 Polymers 0.000 description 11
- 239000006783 corn meal agar Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 8
- 230000004660 morphological change Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 229960002413 ferric citrate Drugs 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 206010017533 Fungal infection Diseases 0.000 description 4
- 208000031888 Mycoses Diseases 0.000 description 4
- 241000235645 Pichia kudriavzevii Species 0.000 description 4
- 240000003705 Senecio vulgaris Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- -1 citrate-caffeic acid Chemical compound 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 244000053095 fungal pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000222178 Candida tropicalis Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000006160 differential media Substances 0.000 description 2
- 239000012449 sabouraud dextrose agar Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- MOWLUBGHVYJYTK-UHFFFAOYSA-N 3-(2-aminoethyl)indol-3-ol Chemical compound C1=CC=C2C(CCN)(O)C=NC2=C1 MOWLUBGHVYJYTK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- XZHWAGZSWOAEPI-UHFFFAOYSA-N C(C=CC1=CC(O)=C(O)C=C1)(=O)O.OC=1C=C(C=CC(=O)O)C=CC1O Chemical compound C(C=CC1=CC(O)=C(O)C=C1)(=O)O.OC=1C=C(C=CC(=O)O)C=CC1O XZHWAGZSWOAEPI-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RINSJDWDXSWUOK-UHFFFAOYSA-N OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 Chemical compound OC(=O)C1=CC=C(O)C(O)=C1.OC(=O)C1=CC=C(O)C(O)=C1 RINSJDWDXSWUOK-UHFFFAOYSA-N 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/165—Yeast isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/72—Candida
- C12R2001/725—Candida albicans
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/921—Candida
- Y10S435/922—Candida albicans
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
ããé¢ããèŠãã°æ¬çºæã¯ãªãã¯ã¹ãŽãŒã«çè
æ±ãšãã¹ã粟補ãµããã³ãããšããŒã«ãªãã·ããŒ
ãŒã®åºè³ªããã³æ¯æå€äŸãã°å¯å€©ãå«ãçèå¢æ®
å¹å°ã«é¢ãããã®ã§ãããå¥ã®é¢ããèŠãã°æ¬çº
æã¯ç åæ§é µæ¯åçèã®æ€åºãšåå®ã®ããã®éå¥
å¹å°ã«é¢ãããã®ã§ãããæŽã«å¥ã®é¢ããèŠãã°
æ¬çºæã¯æ°Žãå ãããšäœæ¶²è©Šæäžã«ååšãããã
ã€ãã®ãããµããç åèã®éããªéå¥åæã«åœ¹ç«
ã€å¢æ®å¹å°ãäžãã貯èµå¯èœãªä¹Ÿç¥çèå¹å°è£œå€
ã«é¢ãããã®ã§ãããæŽã«å¥ã®é¢ããèŠãã°æ¬çº
æã®çèå¹å°ã¯ç¹ã«ïŒçš®ã®å»çäžéèŠãªçèãã«
ã³ãžãã»ã¢ã«ãã«ã³ã¹ããã³ã¯ãªããã³ãã«ã¹ã»
ããªããªã«ãã³ã¹ã®æ€åºãšéå¥ã®ããã®éãã§ä¿¡
é Œæ§ã®é«ãæ¹æ³ãäžããã æ£åžžãªæ¡ä»¶äžã§ã¯çš®ã ã®åã®é µæ¯ïŒã€ãŸãå现
èèïŒãäœå ã«éç åèãšããŠååšããŠããŠãã
ã¯ãäœå ã«ååšããæ£åžžãªåã®çŽ°èã«ãã€ãŠçè
ã®å¢æ®ã調ç¯ãããŠããããã«æ£åžžãªäœæ©èœãé»
害ããããšã¯ãªãããããæ£è ã现èææçã®æ²»
çãåãããšäŸãã°æèæ§æçç©è³ªã®äœ¿çšãéã
ãŠæ£åžžãªçŽ°èâçèã®åè¡¡ãç Žãããçèææç
ãçŸå®çå¯èœæ§ãæã€ããã«ãªããã¬ã³æ£è ã¯æ
äžãããè€åæèå€ãšç¡èœã«ãªã€ãå ç«ç³»ã®ãã
ã«ç¹ã«çèææçã«ãããæããçèææçã¯ç¹
ã«æ£è ãäŸãã°çŽ°èææçã«ãã€ãŠæ¢ã«è¡°åŒ±ããŠ
ããå Žåã«ã¯æ£è ã®å®¹äœãæ¥éã«æªåããããã
ã®çèææçã«ãã€ãŠéç äŸãã°è³èçãèªçºã
ããããšãããã å»çäžæãéèŠãªçèã®ãã¡ã®ïŒçš®ã¯ã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ãšã¯ãªããã³ãã«ã¹ã»ããªããª
ã«ãã³ã¹ã§ãããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã¯äººé
ã®èè žç®¡å ã«ååšããéç åèã§ããããããã
ãæ¡ä»¶äžã§ã¯ãã®é µæ¯ã䟵襲æ§ãšãªãã衰匱ãã
æ£è ã®å Žåã«ã¯éãåžžãšããŠèŽåœçãªçŸç ãåŒã
èµ·ãããšãããåŸããã¯ãªããã³ãã«ã¹ã»ããªã
ãªã«ãã³ã¹ã¯ãããäžæ¢ç¥çµç³»ã奜ã¿ãçç©åŠç
ã«ç¡é²åãªæ£è ã®å Žåã«ã¯éç ã®åå ãšãªãåŸã
ããç¹ã«éèŠã§ããã ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®æšå®ã«ããåå®ã¯ã
ã®çèãé©åœãªå¹å°ã§å¹³æ¿å¹é€ããŠå¢æ®ãããæ
ã«èµ·ã圢æ ã®å€åã®ã¿ã«äŸåããŠãããã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ã®ååšã瀺ãæåã®åœ¢æ å€åã¯
å¹³æ¿å¹é€ããå现èæ€äœãã䌞匵ããå°ä»å±åšãš
ããŠçŸãããçºèœç®¡ã®åœ¢æã§ããããããã®çºèœ
管ã¯æãšããŠã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®äœããå€
ã«åã€ãŠäŒžåŒµãããã€ã©ã¡ã³ãã«æé·ãããçè
ãå¹³æ¿å¹é€ããŠããïŒãïŒæé以å ã«çºèœç®¡ã圢
æããããªãã°ããã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã
ååšãããšããæšå®ã®æ ¹æ ãäžãã蚌æ ã«ãªãã
第ïŒã®å¢æ®æ®µéã§ã¯äžè¬ã«çç¶äœããã€ã©ã¡ã³ã
ã®æ«ç«¯ã«çŸãããããã®çç¶äœã¯åèèåãšããŠ
ç¥ãããŠãããïŒçš®ã®ã«ã³ãžãå±ã®ã¿ãåèèå
ã圢æãããããã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãšã«
ã³ãžãã»ã¹ãã©ãã€ãã¢ã§ãããåŸã€ãŠåèèå
ã®åœ¢æã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ããŸãã¯ã«ã³ãž
ãã»ã¹ãã©ãã€ãã¢ã®ããããã®ååšã瀺ãã ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã¯èŠ³å¯å¯
èœãªãããªã圢æ å€åã被ãããå¢æ®ãã¿ãŒã³ã
éããŠå现èã®ãŸãŸã§ããã®ã§ã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã¯äžè¬ã«ã«ã³ãžãã»
ã¢ã«ãã«ã³ã¹ã®åå®ãããå°é£ã§ãããšèããã
ããæè¿ãŸã§ã¯ãªããã³ãã«ã¹å±ã®ååšã®ç¢ºèªã«
ã¯ïŒã€ã®åºæ¬çè©Šéšã®ãã¡ã®ïŒã€ä»¥äžããŸãã¯ã
ããã®çµåãã䜿çšãããŠãããåå®æ³ã®ïŒã€ã¯
çèã®çŽ°èã®ãŸããã«ã«ãã»ã«ç¶æ§é ãååšãã
ãã©ãããé¡åŸ®é¡ã§æ€æ»ããããšããæãããã®
ã«ãã»ã«ç¶æ§é ã®æ€æ»ãå©ããããã«æ€äœã墚ã§
å²ããšé»ãèæ¯ã«å¯ŸããŠã¯ã€ããããåéæã®å
ãäžããããã®ã§ã«ãã»ã«ã®æ§åãããæçã«ãª
ããé¡åŸ®é¡æ€æ»ã«ãããã®ã«ãã»ã«ã®åºå®ããã
容æã«ãªããã¯ãªããã³ãã«ã¹å±ãåå®ãããã
ã«äœ¿ããã第ïŒã®æ¹æ³ã¯å°¿çŽ ãšåè²æ瀺è¬ãå«ã
å¹å°ã§ã®æ€äœã®å¹³æ¿å¹é€ã䌎ããã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã¯ãŠã¬ã¢ãŒãŒãšããŠç¥ãã
ãé µçŽ ãäœãã®ã§å°¿çŽ äžã«å«ãŸããçªçŽ ãå解ã
ãŠäœ¿ãèœåãããããã®çµæPHãé«ããªããæ瀺
è¬ã®è²ãå€åãããåŸã€ãŠå°¿çŽ ãå«ãå¹å°äžã§ã®
å¢æ®ã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®å
åšã瀺ããã¯ãªããã³ãã«ã¹å±ãåå®ããããã®
第ïŒã®æ¹æ³ã¯ãã®å±ããã³ãã³æ§ååç©ã補é ã
ãèœåãæã€ããšã«äŸæ ããŠããããã³ãã³æ§å
åç©ãååšããã°ãšãŠçŽ ã®æ·»å ã«ãã€ãŠéèœã®ãŸ
ãã«çŽ«è²ã®ç°ãåºçŸãããã¯ãªããã³ãã«ã¹å±å
ã®ä»ã®çš®ããã³ä»ã®é µæ¯å±ãéœæ§åå¿ã瀺ãã®
ã§ããããã®è©Šéšã®ãã¡ã®ã©ããåç¬ãŸãã¯çµå
ããŠäœ¿ã€ãŠãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³
ã¹ã«ç¹ç°çã§ãªããšããããšã泚æããŠããå¿ èŠ
ãããã åŸã€ãŠåŸæ¥ã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ã
ã³ã¹çš®ãåå®ããããã«è¿œå è©Šéšãè¡ããªããã°
ãªããªãã€ããããã¯çæ°Žåç©ãå«ãäžé£ã®å¹å°
äžã§å¹³æ¿å¹é€ããæã®æ€äœã®å¢æ®ãããã€ã«ã®çº
çŸã䌎ããäŸãã°14çš®é¡ä»¥äžã®çæ°Žåç©ãå¢æ®å¹
å°ã«æ··åããïŒã21æ¥åŸã«ãã®äžã§æ€äœãå¹³æ¿å¹
é€ãããšæ€äœäžã«ã¯ãªããã³ãã«ã¹ã»ããªããªã«
ãã³ã¹ãååšããå¯èœæ§ããããã©ããã瀺ãå¢
æ®ãããã€ã«ãçŸãããããã®çš®ãåå®ãããã
ã®ããïŒã€ã®æ¹æ³ã¯ã¯ã¬ã¢ããã³ãå«ãå¯å€©å¹å°
äžã§çèè©Šæãå¹³æ¿å¹é€ããæ¹æ³ã§ãããããïŒ
ãïŒæ¥ä»¥å ã«æå³ã®ããå¢æ®ãèªãããããªã
ã°ãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã¯ã¯ã¬
ã¢ããã³ãååããèœåãæã€ããšãããã®å¢æ®
ããã®çèã®ååšã瀺ãããšã«ãªãããããä»ã®
é µæ¯å±ããŸãã¯ã¬ã¢ããã³äžã§å¢æ®ãåŸãã®ã§ã
ã®è©Šéšã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã«
ç¹ç°çãªãã®ã§ã¯ãªãã æããå¯äžã®å¥œçµæãäžããç¹ç°çãªåŸæ¥ã®ã¯
ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹è©Šéšã¯ããŒã
ã·ãŒãã¢ã¬ãŒã«ã䜿çšãããã®ã§ãããããŒãã·
ãŒãã¢ã¬ãŒã«äžã§å¹³æ¿å¹é€ãããè©Šæäžã«ã¯ãªã
ãã³ãã«ã¹ã»ããªããªã«ãã³ã¹ãååšããã°ãã®
æ€äœããã¬ãŒãäžã§å¢æ®ããã«åŸã€ãŠïŒæ¥ãïŒé±
é以å ã«ç¬ç¹ã®è€è²ã®æ瀺è²ãçŸãããããšãèŠ
åºããããããŒãã·ãŒãã®æœåºç©ã䜿çšããããš
ã«ãã€ãŠãã®æ¹æ³ã¯æ¹è¯ãããåå®æéãïŒãïŒ
æ¥ã«ççž®ããããåŸã«ãã®è€è²ã®çºè²ã¯é µçŽ ããš
ããŒã«ãªãã·ããŒãŒãšããŒãã·ãŒãã¢ã¬ãŒã«äžã«
ååšããç¹æ®ãªåºè³ªãšã®åå¿ã®çµæã§ããããšã
èŠåºãããããã®çµæå¢æ®å¹å°äžã«çœ®æããšããŒ
ã«äŸãã°ã«ããšãŒé žã䜿çšããããšã«ãã€ãŠåå®
ã«å¿ èŠãªæéãæŽã«çŽ48æéã«ççž®ãããã
Journal Clinical MicrobiologyïŒAugust 1975ïŒ
Vo1.ïŒNo.ïŒïŒp.96â98ã«æ²èŒããããã¯ãªãã
ã³ãã«ã¹ã»ããªããªã«ãã³ã¹åå®ã®ããã®ïŒæé
çè²è©Šéšããšé¡ããHopferãšGroâschelã®è«æ
ã«ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã«
ã«ããšãŒé žã䜿çšããæŽã«å¥ã®å·¥å€«ãçºè¡šãããŠ
ããããã®è«æã§çºè¡šãããŠããæ¹è¯ã¯ã«ããšãŒ
é žãšã¯ãšã³é žç¬¬ïŒéãšãçµåããã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒã«ãªãã·ããŒãŒ
é µçŽ æŽ»æ§ã®åºè³ªãšããŠäœ¿ãããã«çŽè£œåç€äžã«ã
ããã®ååç©ãæ··å ¥ãããããã®ã«ããšãŒé žâã¯
ãšã³é žç¬¬ïŒéãå«æµžãããçŽè£œåç€ã䜿ã€ãŠåå®
æéãæŽã«ïŒãïŒæéã«ççž®ãããããããçŽè£œ
åç€ã«å«æµžãããããã«äœ¿ãã«ããšãŒé žãšã¯ãšã³
é žç¬¬ïŒéã®æº¶æ¶²ã¯å ã«åœããšæ¥µããŠäžå®å®ãªãã
貯èµã«æ·±å»ãªåé¡ãçãããæŽã«ã«ããšãŒé žãšã¯
ãšã³é žç¬¬ïŒéã®çžå¯Ÿæ¿åºŠã埮åŠã§ãçµåãã®åè¡¡
ã厩ãããšæ¿ãçè²ãåŸãããã«ã¯ããé·ãå¹é€
æéãå¿ èŠã§ãããããå Žåã«ã¯éç åæ§ã¯ãªã
ãã³ãã«ã¹çš®ãšããã€ãã®ã«ã³ãžãçš®ã®éç¹ç°ç
çè²ãçŸããããæŽã«ãåå®æéãçŽè£œåç€äžã§
ã®å¹³æ¿å¹é€éå§ããïŒãïŒæéã«ççž®ããããšã¯
ãããã¯ãšã³é žç¬¬ïŒéâã«ããšãŒé žå«æµžåç€äžã§
å¹³æ¿å¹é€ããåã«è©Šæããäžæ¬¡å¹é€ãå¹å°äžã§å¢
æ®ãããªããã°ãªããªãã ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãšã¯ãªããã³ãã«ã¹ã»
ããªããªã«ãã³ã¹ã¯å»çäžæãéèŠãªïŒé µæ¯ã§ã¯
ãããããããã®çèã®äž¡è ã®ååšãåæã«åå®
ããããã«ã¯åŸæ¥ã®ã©ã®è©Šéšæç¶ããŸãã¯å¹å°ã
䜿çšã§ããªãããšã«æ³šç®ãã¹ãã§ãããåŸæ¥ã¯ä»£
ãã«ïŒã€ã®è©Šéšãã€ãŸãïŒã€ã¯ã«ã³ãžãã»ã¢ã«ã
ã«ã³ã¹ã®åå®ã®ããã®è©Šéšã第ïŒã®è©Šéšã¯äŸãã°
äžèšã®è©Šéšã®ãã¡ã®ïŒã€ã§ã¯ãªããã³ãã«ã¹ã»ã
ãªããªã«ãã³ã¹ãåå®ããããã®è©Šéšããè¡ãå¿
èŠããã€ãã æè¿ã«ããšãŒé žããªãã¯ã¹ãŽãŒã«ããã³Atlas
Chemical CompanyããTween 80ã®åæšã§è²©å£²
ãããŠããä¹³åå€ãå«ãã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ãã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ããã³ã«
ã³ãžãã»ã¹ãã©ãã€ãã¢ã®åå®ã®ããã®æ°ããå¹
é€å¹å°ãèŠåºãããããã®å¹å°ã¯Journal of
Clinical MicrobiologyïŒFebruary 1977ïŒVo1.
VïŒNo.ïŒïŒp.236â243ã«æ²èŒãããŠãããã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ãšã¯ãªããã³ãã«ã¹ã»ããªããª
ã«ãã³ã¹ã®æšå®ã«ããåå®ã®ããã®æ°ããå¹é€å¹
å°ããšé¡ããFlemingïŒHopkinsããã³Landã®è«
æã«è¿°ã¹ãããŠãããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã
ãã³ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®äž¡æ¹
ã«ç¹ç°çãªåå®æ¹æ³ãæäŸãããã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã¯åè¿°ã®ã«ããšãŒé ž
âã¯ãšã³é žç¬¬ïŒéãå«æµžãããçŽè£œåç€ã䜿çšã
ãæãããæéããããããTween 80ããªãã¯
ã¹ãŽãŒã«ãã«ããšãŒé žå¹å°ïŒä»¥åŸTOCãšåŒã¶å Ž
åãããïŒã¯å ã«ææã§ãªããæåã®æ¿åºŠã¯ã¯ãš
ã³é žç¬¬ïŒéã®åç€ã®å Žåã»ã©åŸ®åŠã«åŠæ¹ããå¿ èŠ
ããªãã®ã§ããã®å¹å°ã¯ããã€ãã®ç¹ã§æå©ã§ã
ããTOCå¹å°ã®å¯äžã®äžå©ãªç¹ã¯ãã€ã©ã¡ã³ã
ã圢æããé µæ¯ã§ããã«ã³ãžãã»ã¯ã«ã»ã€ãä»®æ§
è糞ã圢æããªãç¹ã§ãããåŸã€ãŠã«ã³ãžãã»ã¢
ã«ãã«ã³ã¹ãŸãã¯ã«ã³ãžãã»ã¹ãã©ãã€ãã¢ã®å
åšã¯å¹³æ¿å¹é€åŸïŒæé以å ã«çºèœç®¡ã®åœ¢æã«ãã€
ãŠæ±ºå®ã§ããããã«ã³ãžãã»ã¯ã«ã»ã€ã®å Žåã«ã¯
TOCå¹å°äžã§ã¯24æéåŸã«ãªã€ãŠããã€ã©ã¡ã³
ãã®åœ¢æã¯å šãèªããããªããããã®é µæ¯ã®ååš
ã¯äŸç¶ãšããŠæ€åºãããªããŸãŸã§ãããæŽã«èª¿è£œ
æžTOCå¹å°ã®æå¹æéã¯è¯å¥œãšã¯ããïŒçŽïŒã
ïŒé±éïŒãå¿è«ããé·ãæå¹æéãæãŸãããå
ããŠTween 80ã¯æ¶²äœçµæç©ãªã®ã§ãTOCå¹å°ã¯
å¿ èŠã«å¿ããŠèª¿è£œããŠäœ¿çšããããã«ç²æ«åœ¢æ ã§
容æã«è²¯èµã§ããå®å šã«è±æ°Žãã也ç¥ç²äœçµæç©
ã®åŠæ¹ã«ã¯é©ããŠããªããããããã®å¹å°ã¯ã«ã³
ãžãã»ã¢ã«ãã«ã³ã¹ãã«ã³ãžãã»ã¹ãã©ãã€ãã¢
ããã³ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®å
åšãåå®ããåäžã®è©Šéšæäœãäžããã ãã®ããã«éèŠãªçš®ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã
ãã³ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ãå«ã
ãçš®ã ã®çèç åèãåå®ããéå¥ããããã«
çš®ã ã®æ¹æ³ãšå¹å°ã䜿çšãããŠãããããããã®
çš®ãšä»ã®æ¥åèŠçèãéãã«åå®éå¥ã§ãã調補
ãšäœ¿çšãæ¯èŒç容æã§ãæ¯èŒçé·ãæå¹æéãæ
ã€çèå¢æ®å¹å°ã«å¯ŸããèŠæ±ã¯çµ¶ããªãã æ¬çºæã«ããã°äŸãã°å ç«æå¶å€ã®æäžãåã
ãŠããæ£è ã®å Žåã®ããã«ãªããæ¡ä»¶äžã§ã¯ç å
æ§ãšãªãåŸãçèãéãã«ãããŠä¿¡é Œæ§ããåå®
ã§ããçèå¢æ®å¹å°ãåŸããããæ¬çºæã®çèå¹
å°ã¯åºæ¬çã«ã¯ãªãã¯ã¹ãŽãŒã«ã粟補ãµããã³ã
ããšããŒã«ãªãã·ããŒãŒåºè³ªããã³æ¯æå€ãå«
ãã奜ãŸããã¯ã«ããšãŒé žã®åœ¢æ ããšãããšããŒ
ã«ãªãã·ããŒãŒåºè³ªã䜿çšãããšã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒã«ãªãã·ããŒãŒ
åºè³ªã«ç¹ç°çãªé µçŽ 掻æ§ã®çµæã§ããç¹åŸŽçãªè€
è²ã®çè²ã®åºçŸã«ãã€ãŠã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ãç¹ç°çã«åå®ããããšãã§ããã
ãªãã¯ã¹ãŽãŒã«ã¯éç åèãæå¶ããå ¬ç¥ã®æ©èœ
ã®ä»ã«ãå»çäžéèŠãªçèã«ã³ãžãã»ã¢ã«ãã«ã³
ã¹ããã³ã«ã³ãžãã»ã¹ãã©ãã€ãã¢ããã€ã©ã¡ã³
ããšåèèåãçç£ããã®ãä¿é²ããæ©èœã瀺ã
ããšãèŠåºãããŠããããã®çºæã®çèå¹å°ã«äœ¿
çšããã粟補ãµããã³ã¯ã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ã®ååšãæ瀺ããè€è²ã®çè²ãèã
ãå¢ããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãšã«ã³ãžãã»ã¹
ãã©ãã€ãã¢ã®çºèœç®¡ãšåèèåã®çç£ãé«ãã
ã®ã§ããããã®çèãšãããå±éºãªç åæ§çèã®
極ããŠéããªåå®ãå¯èœã«ãªããäŸãã°æ®éã®å¯
倩ãŸãã¯ã·ãªã«ã²ã«ã®ãããªæ äœã¯åã«äžè¿°ã®æŽ»
æ§æåã®æ¯æäž»å€ã§ããã æ¬çºæã®å¢æ®å¹å°ã¯å»çäžæãéèŠãªåã®æœåš
çç åæ§çèã®ãã¡ã®ïŒçš®é¡ã®çèã®åå®ã®ãã
ã®åªããéå¥å¹å°ãäžãããæ¬çºæã®å¹å°ã¯ã¯ãª
ããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã«ç¹ç°ç
ã§ãããã«ã³ãžãå±ã®ã¢ã«ãã«ã³ã¹ãŸãã¯ã¹ãã©
ãã€ãã¢çš®ã®ããããã®ååšãéãã«æ瀺ããã
ãã®ïŒã€ã®ã«ã³ãžãçš®ã®éå¥ã¯ä»å çãªåŸæ¥ã®é
å¥è©ŠéšäŸãã°ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã¯ã¹ã¯ããŒ
ã¹ãååããã«ã³ãžã»ã¹ãã©ãã€ãã¢ã¯ååããª
ãã®ã§ãç³ã¹ã¯ããŒã¹è©Šéšãè¡ãããšã«ãã€ãŠçº
ããããæŽã«æ¬çºæã®å¢æ®å¹å°ã¯ç¹åŸŽçãªåœ¢æ ãš
çè²ãäžå€ã«ä¿ãããããšã«ãã€ãŠãã€ã©ã¡ã³ã
ã圢æããé µæ¯ã®ä»ã®å±ã®åå®ã«ã圹ç«ã€ãäŸã
ã°ã«ã³ãžãã»ã¯ã«ã»ã€ãšã«ã³ãžãã»ãããã«ãªã¹
ã¯æ¬çºæã®å¹å°äžã§ã¯çœè²ã®ãã€ã©ã¡ã³ã圢æé µ
æ¯ã®ãŸãŸã§ããã æ¬çºæã®éå¥å¹å°ã䜿çšããããšã®äž»ãªå©ç¹ã¯
ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ãšã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ã®åå®ã«ãããå¹å°ã®è¿ éæ§ãš
ç¹ç°æ§ã§ããããã®ããã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ã¯æ¬çºæã®å¢æ®å¹å°äžã§è©Šæãå¹³æ¿
å¹é€ããŠããïŒãïŒæé以å ã«è£žçŒã§èŠ³å¯å¯èœãª
ååšãæ瀺ããè€è²ã®çè²ã«ãã€ãŠåå®ãããã
ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãŸãã¯ã«ã³ãžãã»ã¹ãã©
ãã€ãã¢ã®ååšã¯å¹³æ¿å¹é€åŸçŽïŒãçŽ18æé以å
ã«æ±ºå®ã§ãããã®æç¹ã§çºèœç®¡ãšåèèåããã
ããé¡åŸ®é¡æ€æ»ã§èŠ³å¯ã§ãããã«ã³ãžãå±ã®ã¢ã«
ãã«ã³ã¹ãšã¹ãã©ãã€ãã¢çš®ã®ã¿ãçºèœç®¡ãšåè
èåã圢æããã®ã§ãã©ã¡ãã®çš®ãååšããã®ã
ãåå®ããããã«åäžã®åŸæ¥ã®éå¥è©Šéšãè¡ã€ãŠ
ãããã äžè¿°ã®æãŸããçµæãåŸãããã«äŸãã°å¯å€©ã®
ãããªæ¯æåªè³ªãšãšãã«ïŒçš®ã®æŽ»æ§æåã®çµåã
ã䜿çšã§ããããšãèŠåºãããçã®èæ±ããæ°Žå
ãæ¥éã«èžçºãããŠäœã€ãè±æ°Žæ°é®®çèæ±ã§ã
ããçã®èã®ãäžã«ååšããç©è³ªã®èªå°äœã§ãã
ãªãã¯ã¹ãŽãŒã«ãDIFCO LABORATORIES
ïŒç±³åœãã·ã¬ã³å·ãããã€ãåžïŒã補é ãCode
No.0128â01âïŒã®äžã«åžè²©ããŠããããã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ãšã¹ãã©ãã€ãã¢ã®ãã€ã©ã¡ã³
ããšåèèåã®æé·ãä¿é²ããããã«äœ¿çšããã
ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒ
ã«ãªãã·ããŒãŒé µçŽ ãšç¬¬ïŒã®æåäŸãã°ã«ããšãŒ
é žãŸãã¯ããçš®ã®ä»ã®ããšããŒã«ãªãã·ããŒãŒé µ
çŽ åºè³ªãšã®åå¿ã§ã¯ãªããã³ãã«ã¹ã»ããªããªã«
ãã³ã¹ã«ç¹ç°çãªè€è²ã®çè²ãçããã®ã§ãã®åº
質ãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®åå®
å€ãšããŠäœ¿çšãããæ¬çºæã®çèå¹å°ã«äœ¿çšãã
第ïŒã®æåã¯ç²Ÿè£œãµããã³ã§ãããäžè¬ã«ãµãã
ã³ã¯æ€ç©äžã«åºãååžããŠããé ç³äœã§ãæ°Žäžæ²¹
åä¹³æ¿æ¶²ã圢æãããèœåãæã¡ãä¿è·ã³ãã€ã
ãšããŠåããåãµããã³ååã¯ãã®ååã®ã¢ã°ãª
ã³ã³ãæ§æãããµãã²ãã³ãšç³ãšããæããæãŸ
ããçµæãåŸãã«ã¯ç²Ÿè£œãµããã³ã®ã¿ã䜿çšã§ã
ãããšã¯æ³šç®ã«æ€ãããæªç²Ÿè£œãµããã³ãšéã€ãŠ
粟補ãµããã³ã¯åŸ®çç©ç åäœäŸãã°æ¬çºæã®å¹å°
ã䜿ã€ãŠåå®ãè¡ãé µæ¯ã«å¯ŸããŠç¡æ¯ã§ãããäž
è¬ã«1975幎ïŒæ13æ¥ä»ã®åè¡åœç¹èš±ç¬¬3883425å·
ããµããã³ã®ç¡æ¯åãã«çºè¡šãããŠããæ¹æ³ã䜿
çšããŠãµããã³ã粟補ããŠãããã®ç²Ÿè£œãµããã³
ãæ¬çºæã®çèå¹å°ã«äœ¿çšã§ãããæ¬çºæã®çè
å¹å°äžã«ååšãããµããã³ã®å³å¯ãªæ©èœã¯æªç¥ã§
ãããããµããã³ãä¹³åå¹æãæã€ããã«äœæ¶²è©Š
æäžã«ååšãã现èéåããåçè现èãåé¢ã
ããåŸåã瀺ãããšã¯çè«ã¥ããããããã®åé¢
ã«ãã€ãŠããšããŒã«ãªãã·ããŒãŒåºè³ªãšã¯ãªãã
ã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒã«ãªãã·
ããŒãŒé µçŽ ãšã®åå¿ãå©ãããããã®çµæç¹åŸŽç
ãªè€è²ã®çè²ãããè¿ éã«çŸããããã®ãšæãã
ãã æ¬çºæã®çèå¹å°ã«äœ¿çšããããšããŒã«ãªãã·
ããŒãŒåºè³ªã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³
ã¹ã®ååšäžã§è€è²ã®çè²ãçããããšãç¥ãããŠ
ãããããªãå ¬ç¥ã®åºè³ªããéžæããŠããããé©
åœãªããšããŒã«ãªãã·ããŒãŒåºè³ªã«ã¯ïŒïŒïŒâãž
ããããã·å®æ¯éŠé žãïŒïŒïŒâãžããããã·å®æ¯
éŠé žïŒãããã«ãã¯é žïŒãDOPAãïŒïŒïŒâãžã
ãããã·ã±ã€ç®é žïŒã«ããšãŒé žïŒãã«ããšãŒé žã®
ã¡ãã«ãšã¹ãã«ããã³äºé ¢é žãšã¹ãã«ãïŒâãã
ããã·ããªãã¿ãã³ãïŒïŒïŒâãžããããã·ããš
ãã«ãšã¿ããŒã«ã¢ãã³ïŒãã«ãšããããªã³ïŒãã
ãã³ïŒâããããã·âïŒïŒïŒâãžã¡ããã·ã±ã€ç®
é žãªã©ããããçºè²ã¯ããšãã«ç°ã®ïŒïŒïŒâäœã«
ããæ°Žé žåºã«äŸåãããã®ãšæããããäžèšã®ã
ãšããŒã«ãªãã·ããŒãŒåºè³ªã®ãã¡ã§å¥œãŸããåºè³ª
ã¯ã«ããšãŒé žã§ããã æ¬çºæã®çèå¹å°ã次ã®ããã«ããŠè£œé ã§ã
ãããªãã¯ã¹ãŽãŒã«ã粟補ãµããã³ããã³ããšã
ãŒã«ãªãã·ããŒãŒåºè³ªãé©åœéã®ç²äœæ¯æå€äŸã
ã°å¯å€©ãšãšãã«èžçæ°Žã«æ·»å ãããåŸãããæ··å
ç©ã次ã«ããæ··ããå ç±æ²žéš°ãããŠãããã®æå
ã溶液ã«æº¶è§£ãããã次ã«ãã®æº¶æ¶²ãçŽ121âå§
åçŽ15psiã§çŽ15åéæ» èãããæ» èããŠå°ãå·
åŽããåŸã«éåžžã®åã®ãããªç¿ã«ãã®å¹å°ã泚ã
蟌ã¿ãåºåãããåŸã«ãå¹³æ¿ãè£è¿ãã宀枩ã§ïŒ
æ©ä¹Ÿç¥ããããåŸããããããªç¿ãä¿åã®ããã«
å·èµããããšãã§ããããã¯çŽïŒé±éãŸã§ã®æå¹
æéãæã€ã äžè¬ã«æ¬çºæã®çèå¹å°ã¯æåã«æ·»å ããæ°Žã®
éãåºæºã«ããŠçŽ0.25ãçŽ30ééïŒ ã®ãªãã¯ã¹ãŽ
ãŒã«ãçŽïŒãçŽïŒééïŒ ã®æ¯æå€ãçŽ0.1ãçŽ5.0
ééïŒ ã®ç²Ÿè£œãµããã³ãããã³çŽ0.001ãçŽ1.0é
éïŒ ã®ããšããŒã«ãªãã·ããŒãŒåºè³ªãå«ãã 奜ãŸããã¯äžèšã®æé ã«åŸã也ç¥æåã«æ·»å ã
ãæ°Žã®éãåºæºã«ããŠçŽ0.5ãçŽïŒééïŒ ã®ãªã
ã¯ã¹ãŽãŒã«ãçŽïŒãçŽïŒééïŒ ã®å¯å€©ãçŽ0.1ã
çŽ1.0ééïŒ ã®ç²Ÿè£œãµããã³ããã³çŽ0.005ãçŽ
0.05ééïŒ ã®ã«ããšãŒé žã䜿çšããŠå¹å°ã補é ã§
ãããæã奜ãŸããå¹å°ã¯çŽ1.0ééïŒ ã®ãªãã¯
ã¹ãŽãŒã«ãçŽ2.0ééïŒ ã®å¯å€©ãçŽ0.5ééïŒ ã®ç²Ÿ
補ãµããã³ããã³çŽ0.03ïŒ ã®ã«ããšãŒé žãå«ãå¹
å°ã§ãããæ¬çºæã®çèå¹å°ã®å©ç¹ã®ïŒã€ã¯å šãŠ
ã®æåïŒæ°Žãé€ãïŒãç²äœã§ããããã«äºã秀é
ããåæåãçèå¹å°è£œå€ãšããŠçµåãããŠä¹Ÿç¥
ç¶æ ã®ãŸãŸãã€ãŸã§ã貯èµã§ããå¿ èŠã«å¿ããŠäž
ã«è¿°ã¹ãéåžžã®æé ã«åŸã€ãŠæ°Žãæ·»å ããããšã«
ãã€ãŠå¹å°ã補é ã§ããããšã§ããããšãè¿°ã¹ãŠ
ããå¿ èŠãããã æ¬çºæã®çèå¹å°ãã¯ãªããã³ãã«ã¹ã»ããªã
ãªã«ãã³ã¹ãšã«ã³ãžãã»ã¹ãã©ãã€ãã¢ã®æ¯èŒç
è¿ éãªéå¥åå®ã®ããã®äžæ¬¡å¹é€ãŸãã¯äºæ¬¡å¹é€
å¹å°ãšããŠäœ¿çšã§ãããäžæ¬¡å¹é€å¹å°ãšããŠäœ¿çš
ããå Žåã«ã¯äœæ¶²è©ŠæïŒäŸãã°è¡æ¶²ãåŸæ¶²ãŸãã¯
å°¿ïŒãSOCå¹å°äžã§çŽæ¥å¹³æ¿å¹é€ããçèå¢æ®
ã«é©ããæ¡ä»¶ãæŽããŠãããäºæ¬¡å¹é€æ³ã®å Žåã«
ã¯ãäœæ¶²è©ŠæããŸãäžæ¬¡å¹å°äŸãã°ãµãããŒå¯å€©
ã§å¹³æ¿å¹é€ããããã«ååšããå šçèãããªãè¿
éã«åæå¢æ®ããããã®åæå¢æ®ãèµ·ã€ãŠããã
ã®çèãæ¬çºæã®SOCå¹å°ã®äžã§ç»ç·å¹é€ãã
ããšçš®ã ã®çèçš®ã®éå¥ãéãã«è¡ãããšãã§ã
ãã äŸ ä»¥äžã®äŸã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãã«ã³ãž
ãã»ã¹ãã©ãã€ãã¢ããã³ã¯ãªããã³ãã«ã¹ã»ã
ãªããªã«ãã³ã¹ãå«ããçš®ã ã®çèã®éå¥ã«å¯Ÿã
ãŠæ¬çºæã®çèå¹å°ã®æ¹ãåŸæ¥ã®ãã®ãããæå©
ã§ããããšã蚌æãããã®ã§ããããããã®äŸã¯
æ¬çºæãããããç解ããŠãããããã«ç€ºããã®
ã§ãã€ãŠããã®ç¯å²ãéå®ãããã®ãšè§£éããŠã¯
ãªããªãã äŸ ãã®äŸã¯ã³ãŒã³ããŒã«ã¢ã¬ãŒã«ïŒCMAïŒã
ã«ããšãŒé žããªãã¯ã¹ãŽãŒã«ããã³Tween 80ã
ãæãå¹å°ïŒTOCïŒããã³ç²Ÿè£œãµããã³ããªã
ã¯ã¹ãŽãŒã«ãããã³ã«ããšãŒé žã®æ··åç©ããæã
æ¬çºæã®çèå¹å°ïŒSOCïŒäžã§å¹³æ¿å¹é€ããç
èã®ç¹æ§åœ¢æ å€åãèµ·ãã®ã«èŠããæéãæ¯èŒã
ãããã«è¡ã€ããã®ã§ããã ã¡ãŒã«ãŒã®äœ¿çšèª¬ææžã«åŸãã0.1ïŒ Tween 80
ãè¿œå ããŠCMAã調補ãããTween 80ããªãã¯
ã¹ãŽãŒã«ãã«ããšãŒé žãããã³ãã€ãã¹å¯å€©ãã
æãTOCå¹å°ã次ã®ããã«ããŠèª¿è£œããããªã
ã¯ã¹ãŽãŒã«10ïœãå¯å€©20ïœã10ïŒ Tween 80溶液
10mlãã«ããšãŒé ž0.3ïœãèžçæ°ŽïŒã«å ããã
ãã®æ··åç©ãããæ··ããå ç±æ²žéš°ãããŠãããã®
æåã溶液ã«æº¶è§£ãããçŽ120âã®æž©åºŠçŽ15psiã®
å§åäžã§15åéæ» èãããæ» èãçµãå°ãå·ããŠ
ãããã®å¹å°ããããªç¿ã«æ³šã蟌ãã ãæ¬çºæã®
è©Šéšå¹å°SOCã次ã®ããã«ããŠèª¿è£œããããªã
ã¯ã¹ãŽãŒã«10ïœãå¯å€©20ïœã粟補ãµããã³ïŒïœã
ãã³ã«ããšãŒé ž0.3ïœãèžçæ°Žã«å ããããã®æ··
åç©ãããæ··ããå ç±æ²žéš°ãããŠæåã溶液ã«æº¶
解ããã120âã®æž©åºŠ15psiã®å§åäžã§15åéæ» è
ãããæ» èãçµãå°ãå·ããŠãããã®å¹å°ããã
ãªç¿ã«æ³šã蟌ã¿ãåºåãããã ä¿åé µæ¯æ ªããµãããŒãããŠç³å¯å€©äžã«æ€ç¶ã
ãã72æéå¢æ®ããããäžæ¬¡å¹³æ¿äžã§ã®å¢æ®ãæ¬
ãããã®äºåå¢æ®ã®åŸã«ããã«ã¢âæ³ã«ãã€ãŠç
èãCMAïŒTOCããŸãã¯SOCå¹å°ã®äžã«æ€ç¶ã
ããããã®æ¹æ³ã¯åã«åŸ®çç©ãæ¥çš®ãããé¢ã«ã«
ããŒã°ã©ã¹ã眮ããå¹³æ¿ã®æ¥çš®é¢ãé¡åŸ®é¡ã§èŠ³å¯
ã§ããããã«ããã ãã§ããã倧éã®æ¥çš®ææã
åŸãããã«æ» è綿æ£ã䜿ã€ãŠãµãããŒãããŠç³å¯
倩平æ¿äžã®éèœãéããã CMAïŒTOCãããã³SOCäžã§ã®ã«ã³ãžãã»ã¢
ã«ãã«ã³ã¹ã®åèèåçç£ã«èŠããæéãæ¯èŒã
ãããã«è¡ã€ãè©Šéšã®çµæãè¡šïŒã«ç€ºãã138ã®
匧ç«ããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãå¹³æ¿å¹é€ããŠ
è¡šïŒã«æèšããæéééã§èŠ³å¯ããã次ã«åå¹å°
ã«ã€ããŠé¡åŸ®é¡ã®100Ãã®èŠéåœãã®çç£ããã
åèèåæ°ãèšé²ãããåå¹å°äžã®åŒ§ç«æ ªã¯å šãŠ
å®è³ªçã«åäžã®ç°å¢ãäžããããã
æ±ãšãã¹ã粟補ãµããã³ãããšããŒã«ãªãã·ããŒ
ãŒã®åºè³ªããã³æ¯æå€äŸãã°å¯å€©ãå«ãçèå¢æ®
å¹å°ã«é¢ãããã®ã§ãããå¥ã®é¢ããèŠãã°æ¬çº
æã¯ç åæ§é µæ¯åçèã®æ€åºãšåå®ã®ããã®éå¥
å¹å°ã«é¢ãããã®ã§ãããæŽã«å¥ã®é¢ããèŠãã°
æ¬çºæã¯æ°Žãå ãããšäœæ¶²è©Šæäžã«ååšãããã
ã€ãã®ãããµããç åèã®éããªéå¥åæã«åœ¹ç«
ã€å¢æ®å¹å°ãäžãã貯èµå¯èœãªä¹Ÿç¥çèå¹å°è£œå€
ã«é¢ãããã®ã§ãããæŽã«å¥ã®é¢ããèŠãã°æ¬çº
æã®çèå¹å°ã¯ç¹ã«ïŒçš®ã®å»çäžéèŠãªçèãã«
ã³ãžãã»ã¢ã«ãã«ã³ã¹ããã³ã¯ãªããã³ãã«ã¹ã»
ããªããªã«ãã³ã¹ã®æ€åºãšéå¥ã®ããã®éãã§ä¿¡
é Œæ§ã®é«ãæ¹æ³ãäžããã æ£åžžãªæ¡ä»¶äžã§ã¯çš®ã ã®åã®é µæ¯ïŒã€ãŸãå现
èèïŒãäœå ã«éç åèãšããŠååšããŠããŠãã
ã¯ãäœå ã«ååšããæ£åžžãªåã®çŽ°èã«ãã€ãŠçè
ã®å¢æ®ã調ç¯ãããŠããããã«æ£åžžãªäœæ©èœãé»
害ããããšã¯ãªãããããæ£è ã现èææçã®æ²»
çãåãããšäŸãã°æèæ§æçç©è³ªã®äœ¿çšãéã
ãŠæ£åžžãªçŽ°èâçèã®åè¡¡ãç Žãããçèææç
ãçŸå®çå¯èœæ§ãæã€ããã«ãªããã¬ã³æ£è ã¯æ
äžãããè€åæèå€ãšç¡èœã«ãªã€ãå ç«ç³»ã®ãã
ã«ç¹ã«çèææçã«ãããæããçèææçã¯ç¹
ã«æ£è ãäŸãã°çŽ°èææçã«ãã€ãŠæ¢ã«è¡°åŒ±ããŠ
ããå Žåã«ã¯æ£è ã®å®¹äœãæ¥éã«æªåããããã
ã®çèææçã«ãã€ãŠéç äŸãã°è³èçãèªçºã
ããããšãããã å»çäžæãéèŠãªçèã®ãã¡ã®ïŒçš®ã¯ã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ãšã¯ãªããã³ãã«ã¹ã»ããªããª
ã«ãã³ã¹ã§ãããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã¯äººé
ã®èè žç®¡å ã«ååšããéç åèã§ããããããã
ãæ¡ä»¶äžã§ã¯ãã®é µæ¯ã䟵襲æ§ãšãªãã衰匱ãã
æ£è ã®å Žåã«ã¯éãåžžãšããŠèŽåœçãªçŸç ãåŒã
èµ·ãããšãããåŸããã¯ãªããã³ãã«ã¹ã»ããªã
ãªã«ãã³ã¹ã¯ãããäžæ¢ç¥çµç³»ã奜ã¿ãçç©åŠç
ã«ç¡é²åãªæ£è ã®å Žåã«ã¯éç ã®åå ãšãªãåŸã
ããç¹ã«éèŠã§ããã ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®æšå®ã«ããåå®ã¯ã
ã®çèãé©åœãªå¹å°ã§å¹³æ¿å¹é€ããŠå¢æ®ãããæ
ã«èµ·ã圢æ ã®å€åã®ã¿ã«äŸåããŠãããã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ã®ååšã瀺ãæåã®åœ¢æ å€åã¯
å¹³æ¿å¹é€ããå现èæ€äœãã䌞匵ããå°ä»å±åšãš
ããŠçŸãããçºèœç®¡ã®åœ¢æã§ããããããã®çºèœ
管ã¯æãšããŠã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®äœããå€
ã«åã€ãŠäŒžåŒµãããã€ã©ã¡ã³ãã«æé·ãããçè
ãå¹³æ¿å¹é€ããŠããïŒãïŒæé以å ã«çºèœç®¡ã圢
æããããªãã°ããã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã
ååšãããšããæšå®ã®æ ¹æ ãäžãã蚌æ ã«ãªãã
第ïŒã®å¢æ®æ®µéã§ã¯äžè¬ã«çç¶äœããã€ã©ã¡ã³ã
ã®æ«ç«¯ã«çŸãããããã®çç¶äœã¯åèèåãšããŠ
ç¥ãããŠãããïŒçš®ã®ã«ã³ãžãå±ã®ã¿ãåèèå
ã圢æãããããã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãšã«
ã³ãžãã»ã¹ãã©ãã€ãã¢ã§ãããåŸã€ãŠåèèå
ã®åœ¢æã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ããŸãã¯ã«ã³ãž
ãã»ã¹ãã©ãã€ãã¢ã®ããããã®ååšã瀺ãã ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã¯èŠ³å¯å¯
èœãªãããªã圢æ å€åã被ãããå¢æ®ãã¿ãŒã³ã
éããŠå现èã®ãŸãŸã§ããã®ã§ã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã¯äžè¬ã«ã«ã³ãžãã»
ã¢ã«ãã«ã³ã¹ã®åå®ãããå°é£ã§ãããšèããã
ããæè¿ãŸã§ã¯ãªããã³ãã«ã¹å±ã®ååšã®ç¢ºèªã«
ã¯ïŒã€ã®åºæ¬çè©Šéšã®ãã¡ã®ïŒã€ä»¥äžããŸãã¯ã
ããã®çµåãã䜿çšãããŠãããåå®æ³ã®ïŒã€ã¯
çèã®çŽ°èã®ãŸããã«ã«ãã»ã«ç¶æ§é ãååšãã
ãã©ãããé¡åŸ®é¡ã§æ€æ»ããããšããæãããã®
ã«ãã»ã«ç¶æ§é ã®æ€æ»ãå©ããããã«æ€äœã墚ã§
å²ããšé»ãèæ¯ã«å¯ŸããŠã¯ã€ããããåéæã®å
ãäžããããã®ã§ã«ãã»ã«ã®æ§åãããæçã«ãª
ããé¡åŸ®é¡æ€æ»ã«ãããã®ã«ãã»ã«ã®åºå®ããã
容æã«ãªããã¯ãªããã³ãã«ã¹å±ãåå®ãããã
ã«äœ¿ããã第ïŒã®æ¹æ³ã¯å°¿çŽ ãšåè²æ瀺è¬ãå«ã
å¹å°ã§ã®æ€äœã®å¹³æ¿å¹é€ã䌎ããã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã¯ãŠã¬ã¢ãŒãŒãšããŠç¥ãã
ãé µçŽ ãäœãã®ã§å°¿çŽ äžã«å«ãŸããçªçŽ ãå解ã
ãŠäœ¿ãèœåãããããã®çµæPHãé«ããªããæ瀺
è¬ã®è²ãå€åãããåŸã€ãŠå°¿çŽ ãå«ãå¹å°äžã§ã®
å¢æ®ã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®å
åšã瀺ããã¯ãªããã³ãã«ã¹å±ãåå®ããããã®
第ïŒã®æ¹æ³ã¯ãã®å±ããã³ãã³æ§ååç©ã補é ã
ãèœåãæã€ããšã«äŸæ ããŠããããã³ãã³æ§å
åç©ãååšããã°ãšãŠçŽ ã®æ·»å ã«ãã€ãŠéèœã®ãŸ
ãã«çŽ«è²ã®ç°ãåºçŸãããã¯ãªããã³ãã«ã¹å±å
ã®ä»ã®çš®ããã³ä»ã®é µæ¯å±ãéœæ§åå¿ã瀺ãã®
ã§ããããã®è©Šéšã®ãã¡ã®ã©ããåç¬ãŸãã¯çµå
ããŠäœ¿ã€ãŠãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³
ã¹ã«ç¹ç°çã§ãªããšããããšã泚æããŠããå¿ èŠ
ãããã åŸã€ãŠåŸæ¥ã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ã
ã³ã¹çš®ãåå®ããããã«è¿œå è©Šéšãè¡ããªããã°
ãªããªãã€ããããã¯çæ°Žåç©ãå«ãäžé£ã®å¹å°
äžã§å¹³æ¿å¹é€ããæã®æ€äœã®å¢æ®ãããã€ã«ã®çº
çŸã䌎ããäŸãã°14çš®é¡ä»¥äžã®çæ°Žåç©ãå¢æ®å¹
å°ã«æ··åããïŒã21æ¥åŸã«ãã®äžã§æ€äœãå¹³æ¿å¹
é€ãããšæ€äœäžã«ã¯ãªããã³ãã«ã¹ã»ããªããªã«
ãã³ã¹ãååšããå¯èœæ§ããããã©ããã瀺ãå¢
æ®ãããã€ã«ãçŸãããããã®çš®ãåå®ãããã
ã®ããïŒã€ã®æ¹æ³ã¯ã¯ã¬ã¢ããã³ãå«ãå¯å€©å¹å°
äžã§çèè©Šæãå¹³æ¿å¹é€ããæ¹æ³ã§ãããããïŒ
ãïŒæ¥ä»¥å ã«æå³ã®ããå¢æ®ãèªãããããªã
ã°ãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã¯ã¯ã¬
ã¢ããã³ãååããèœåãæã€ããšãããã®å¢æ®
ããã®çèã®ååšã瀺ãããšã«ãªãããããä»ã®
é µæ¯å±ããŸãã¯ã¬ã¢ããã³äžã§å¢æ®ãåŸãã®ã§ã
ã®è©Šéšã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã«
ç¹ç°çãªãã®ã§ã¯ãªãã æããå¯äžã®å¥œçµæãäžããç¹ç°çãªåŸæ¥ã®ã¯
ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹è©Šéšã¯ããŒã
ã·ãŒãã¢ã¬ãŒã«ã䜿çšãããã®ã§ãããããŒãã·
ãŒãã¢ã¬ãŒã«äžã§å¹³æ¿å¹é€ãããè©Šæäžã«ã¯ãªã
ãã³ãã«ã¹ã»ããªããªã«ãã³ã¹ãååšããã°ãã®
æ€äœããã¬ãŒãäžã§å¢æ®ããã«åŸã€ãŠïŒæ¥ãïŒé±
é以å ã«ç¬ç¹ã®è€è²ã®æ瀺è²ãçŸãããããšãèŠ
åºããããããŒãã·ãŒãã®æœåºç©ã䜿çšããããš
ã«ãã€ãŠãã®æ¹æ³ã¯æ¹è¯ãããåå®æéãïŒãïŒ
æ¥ã«ççž®ããããåŸã«ãã®è€è²ã®çºè²ã¯é µçŽ ããš
ããŒã«ãªãã·ããŒãŒãšããŒãã·ãŒãã¢ã¬ãŒã«äžã«
ååšããç¹æ®ãªåºè³ªãšã®åå¿ã®çµæã§ããããšã
èŠåºãããããã®çµæå¢æ®å¹å°äžã«çœ®æããšããŒ
ã«äŸãã°ã«ããšãŒé žã䜿çšããããšã«ãã€ãŠåå®
ã«å¿ èŠãªæéãæŽã«çŽ48æéã«ççž®ãããã
Journal Clinical MicrobiologyïŒAugust 1975ïŒ
Vo1.ïŒNo.ïŒïŒp.96â98ã«æ²èŒããããã¯ãªãã
ã³ãã«ã¹ã»ããªããªã«ãã³ã¹åå®ã®ããã®ïŒæé
çè²è©Šéšããšé¡ããHopferãšGroâschelã®è«æ
ã«ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã«
ã«ããšãŒé žã䜿çšããæŽã«å¥ã®å·¥å€«ãçºè¡šãããŠ
ããããã®è«æã§çºè¡šãããŠããæ¹è¯ã¯ã«ããšãŒ
é žãšã¯ãšã³é žç¬¬ïŒéãšãçµåããã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒã«ãªãã·ããŒãŒ
é µçŽ æŽ»æ§ã®åºè³ªãšããŠäœ¿ãããã«çŽè£œåç€äžã«ã
ããã®ååç©ãæ··å ¥ãããããã®ã«ããšãŒé žâã¯
ãšã³é žç¬¬ïŒéãå«æµžãããçŽè£œåç€ã䜿ã€ãŠåå®
æéãæŽã«ïŒãïŒæéã«ççž®ãããããããçŽè£œ
åç€ã«å«æµžãããããã«äœ¿ãã«ããšãŒé žãšã¯ãšã³
é žç¬¬ïŒéã®æº¶æ¶²ã¯å ã«åœããšæ¥µããŠäžå®å®ãªãã
貯èµã«æ·±å»ãªåé¡ãçãããæŽã«ã«ããšãŒé žãšã¯
ãšã³é žç¬¬ïŒéã®çžå¯Ÿæ¿åºŠã埮åŠã§ãçµåãã®åè¡¡
ã厩ãããšæ¿ãçè²ãåŸãããã«ã¯ããé·ãå¹é€
æéãå¿ èŠã§ãããããå Žåã«ã¯éç åæ§ã¯ãªã
ãã³ãã«ã¹çš®ãšããã€ãã®ã«ã³ãžãçš®ã®éç¹ç°ç
çè²ãçŸããããæŽã«ãåå®æéãçŽè£œåç€äžã§
ã®å¹³æ¿å¹é€éå§ããïŒãïŒæéã«ççž®ããããšã¯
ãããã¯ãšã³é žç¬¬ïŒéâã«ããšãŒé žå«æµžåç€äžã§
å¹³æ¿å¹é€ããåã«è©Šæããäžæ¬¡å¹é€ãå¹å°äžã§å¢
æ®ãããªããã°ãªããªãã ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãšã¯ãªããã³ãã«ã¹ã»
ããªããªã«ãã³ã¹ã¯å»çäžæãéèŠãªïŒé µæ¯ã§ã¯
ãããããããã®çèã®äž¡è ã®ååšãåæã«åå®
ããããã«ã¯åŸæ¥ã®ã©ã®è©Šéšæç¶ããŸãã¯å¹å°ã
䜿çšã§ããªãããšã«æ³šç®ãã¹ãã§ãããåŸæ¥ã¯ä»£
ãã«ïŒã€ã®è©Šéšãã€ãŸãïŒã€ã¯ã«ã³ãžãã»ã¢ã«ã
ã«ã³ã¹ã®åå®ã®ããã®è©Šéšã第ïŒã®è©Šéšã¯äŸãã°
äžèšã®è©Šéšã®ãã¡ã®ïŒã€ã§ã¯ãªããã³ãã«ã¹ã»ã
ãªããªã«ãã³ã¹ãåå®ããããã®è©Šéšããè¡ãå¿
èŠããã€ãã æè¿ã«ããšãŒé žããªãã¯ã¹ãŽãŒã«ããã³Atlas
Chemical CompanyããTween 80ã®åæšã§è²©å£²
ãããŠããä¹³åå€ãå«ãã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ãã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ããã³ã«
ã³ãžãã»ã¹ãã©ãã€ãã¢ã®åå®ã®ããã®æ°ããå¹
é€å¹å°ãèŠåºãããããã®å¹å°ã¯Journal of
Clinical MicrobiologyïŒFebruary 1977ïŒVo1.
VïŒNo.ïŒïŒp.236â243ã«æ²èŒãããŠãããã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ãšã¯ãªããã³ãã«ã¹ã»ããªããª
ã«ãã³ã¹ã®æšå®ã«ããåå®ã®ããã®æ°ããå¹é€å¹
å°ããšé¡ããFlemingïŒHopkinsããã³Landã®è«
æã«è¿°ã¹ãããŠãããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã
ãã³ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®äž¡æ¹
ã«ç¹ç°çãªåå®æ¹æ³ãæäŸãããã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã¯åè¿°ã®ã«ããšãŒé ž
âã¯ãšã³é žç¬¬ïŒéãå«æµžãããçŽè£œåç€ã䜿çšã
ãæãããæéããããããTween 80ããªãã¯
ã¹ãŽãŒã«ãã«ããšãŒé žå¹å°ïŒä»¥åŸTOCãšåŒã¶å Ž
åãããïŒã¯å ã«ææã§ãªããæåã®æ¿åºŠã¯ã¯ãš
ã³é žç¬¬ïŒéã®åç€ã®å Žåã»ã©åŸ®åŠã«åŠæ¹ããå¿ èŠ
ããªãã®ã§ããã®å¹å°ã¯ããã€ãã®ç¹ã§æå©ã§ã
ããTOCå¹å°ã®å¯äžã®äžå©ãªç¹ã¯ãã€ã©ã¡ã³ã
ã圢æããé µæ¯ã§ããã«ã³ãžãã»ã¯ã«ã»ã€ãä»®æ§
è糞ã圢æããªãç¹ã§ãããåŸã€ãŠã«ã³ãžãã»ã¢
ã«ãã«ã³ã¹ãŸãã¯ã«ã³ãžãã»ã¹ãã©ãã€ãã¢ã®å
åšã¯å¹³æ¿å¹é€åŸïŒæé以å ã«çºèœç®¡ã®åœ¢æã«ãã€
ãŠæ±ºå®ã§ããããã«ã³ãžãã»ã¯ã«ã»ã€ã®å Žåã«ã¯
TOCå¹å°äžã§ã¯24æéåŸã«ãªã€ãŠããã€ã©ã¡ã³
ãã®åœ¢æã¯å šãèªããããªããããã®é µæ¯ã®ååš
ã¯äŸç¶ãšããŠæ€åºãããªããŸãŸã§ãããæŽã«èª¿è£œ
æžTOCå¹å°ã®æå¹æéã¯è¯å¥œãšã¯ããïŒçŽïŒã
ïŒé±éïŒãå¿è«ããé·ãæå¹æéãæãŸãããå
ããŠTween 80ã¯æ¶²äœçµæç©ãªã®ã§ãTOCå¹å°ã¯
å¿ èŠã«å¿ããŠèª¿è£œããŠäœ¿çšããããã«ç²æ«åœ¢æ ã§
容æã«è²¯èµã§ããå®å šã«è±æ°Žãã也ç¥ç²äœçµæç©
ã®åŠæ¹ã«ã¯é©ããŠããªããããããã®å¹å°ã¯ã«ã³
ãžãã»ã¢ã«ãã«ã³ã¹ãã«ã³ãžãã»ã¹ãã©ãã€ãã¢
ããã³ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®å
åšãåå®ããåäžã®è©Šéšæäœãäžããã ãã®ããã«éèŠãªçš®ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã
ãã³ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ãå«ã
ãçš®ã ã®çèç åèãåå®ããéå¥ããããã«
çš®ã ã®æ¹æ³ãšå¹å°ã䜿çšãããŠãããããããã®
çš®ãšä»ã®æ¥åèŠçèãéãã«åå®éå¥ã§ãã調補
ãšäœ¿çšãæ¯èŒç容æã§ãæ¯èŒçé·ãæå¹æéãæ
ã€çèå¢æ®å¹å°ã«å¯ŸããèŠæ±ã¯çµ¶ããªãã æ¬çºæã«ããã°äŸãã°å ç«æå¶å€ã®æäžãåã
ãŠããæ£è ã®å Žåã®ããã«ãªããæ¡ä»¶äžã§ã¯ç å
æ§ãšãªãåŸãçèãéãã«ãããŠä¿¡é Œæ§ããåå®
ã§ããçèå¢æ®å¹å°ãåŸããããæ¬çºæã®çèå¹
å°ã¯åºæ¬çã«ã¯ãªãã¯ã¹ãŽãŒã«ã粟補ãµããã³ã
ããšããŒã«ãªãã·ããŒãŒåºè³ªããã³æ¯æå€ãå«
ãã奜ãŸããã¯ã«ããšãŒé žã®åœ¢æ ããšãããšããŒ
ã«ãªãã·ããŒãŒåºè³ªã䜿çšãããšã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒã«ãªãã·ããŒãŒ
åºè³ªã«ç¹ç°çãªé µçŽ 掻æ§ã®çµæã§ããç¹åŸŽçãªè€
è²ã®çè²ã®åºçŸã«ãã€ãŠã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ãç¹ç°çã«åå®ããããšãã§ããã
ãªãã¯ã¹ãŽãŒã«ã¯éç åèãæå¶ããå ¬ç¥ã®æ©èœ
ã®ä»ã«ãå»çäžéèŠãªçèã«ã³ãžãã»ã¢ã«ãã«ã³
ã¹ããã³ã«ã³ãžãã»ã¹ãã©ãã€ãã¢ããã€ã©ã¡ã³
ããšåèèåãçç£ããã®ãä¿é²ããæ©èœã瀺ã
ããšãèŠåºãããŠããããã®çºæã®çèå¹å°ã«äœ¿
çšããã粟補ãµããã³ã¯ã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ã®ååšãæ瀺ããè€è²ã®çè²ãèã
ãå¢ããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãšã«ã³ãžãã»ã¹
ãã©ãã€ãã¢ã®çºèœç®¡ãšåèèåã®çç£ãé«ãã
ã®ã§ããããã®çèãšãããå±éºãªç åæ§çèã®
極ããŠéããªåå®ãå¯èœã«ãªããäŸãã°æ®éã®å¯
倩ãŸãã¯ã·ãªã«ã²ã«ã®ãããªæ äœã¯åã«äžè¿°ã®æŽ»
æ§æåã®æ¯æäž»å€ã§ããã æ¬çºæã®å¢æ®å¹å°ã¯å»çäžæãéèŠãªåã®æœåš
çç åæ§çèã®ãã¡ã®ïŒçš®é¡ã®çèã®åå®ã®ãã
ã®åªããéå¥å¹å°ãäžãããæ¬çºæã®å¹å°ã¯ã¯ãª
ããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®åå®ã«ç¹ç°ç
ã§ãããã«ã³ãžãå±ã®ã¢ã«ãã«ã³ã¹ãŸãã¯ã¹ãã©
ãã€ãã¢çš®ã®ããããã®ååšãéãã«æ瀺ããã
ãã®ïŒã€ã®ã«ã³ãžãçš®ã®éå¥ã¯ä»å çãªåŸæ¥ã®é
å¥è©ŠéšäŸãã°ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã¯ã¹ã¯ããŒ
ã¹ãååããã«ã³ãžã»ã¹ãã©ãã€ãã¢ã¯ååããª
ãã®ã§ãç³ã¹ã¯ããŒã¹è©Šéšãè¡ãããšã«ãã€ãŠçº
ããããæŽã«æ¬çºæã®å¢æ®å¹å°ã¯ç¹åŸŽçãªåœ¢æ ãš
çè²ãäžå€ã«ä¿ãããããšã«ãã€ãŠãã€ã©ã¡ã³ã
ã圢æããé µæ¯ã®ä»ã®å±ã®åå®ã«ã圹ç«ã€ãäŸã
ã°ã«ã³ãžãã»ã¯ã«ã»ã€ãšã«ã³ãžãã»ãããã«ãªã¹
ã¯æ¬çºæã®å¹å°äžã§ã¯çœè²ã®ãã€ã©ã¡ã³ã圢æé µ
æ¯ã®ãŸãŸã§ããã æ¬çºæã®éå¥å¹å°ã䜿çšããããšã®äž»ãªå©ç¹ã¯
ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ãšã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ã®åå®ã«ãããå¹å°ã®è¿ éæ§ãš
ç¹ç°æ§ã§ããããã®ããã¯ãªããã³ãã«ã¹ã»ããª
ããªã«ãã³ã¹ã¯æ¬çºæã®å¢æ®å¹å°äžã§è©Šæãå¹³æ¿
å¹é€ããŠããïŒãïŒæé以å ã«è£žçŒã§èŠ³å¯å¯èœãª
ååšãæ瀺ããè€è²ã®çè²ã«ãã€ãŠåå®ãããã
ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãŸãã¯ã«ã³ãžãã»ã¹ãã©
ãã€ãã¢ã®ååšã¯å¹³æ¿å¹é€åŸçŽïŒãçŽ18æé以å
ã«æ±ºå®ã§ãããã®æç¹ã§çºèœç®¡ãšåèèåããã
ããé¡åŸ®é¡æ€æ»ã§èŠ³å¯ã§ãããã«ã³ãžãå±ã®ã¢ã«
ãã«ã³ã¹ãšã¹ãã©ãã€ãã¢çš®ã®ã¿ãçºèœç®¡ãšåè
èåã圢æããã®ã§ãã©ã¡ãã®çš®ãååšããã®ã
ãåå®ããããã«åäžã®åŸæ¥ã®éå¥è©Šéšãè¡ã€ãŠ
ãããã äžè¿°ã®æãŸããçµæãåŸãããã«äŸãã°å¯å€©ã®
ãããªæ¯æåªè³ªãšãšãã«ïŒçš®ã®æŽ»æ§æåã®çµåã
ã䜿çšã§ããããšãèŠåºãããçã®èæ±ããæ°Žå
ãæ¥éã«èžçºãããŠäœã€ãè±æ°Žæ°é®®çèæ±ã§ã
ããçã®èã®ãäžã«ååšããç©è³ªã®èªå°äœã§ãã
ãªãã¯ã¹ãŽãŒã«ãDIFCO LABORATORIES
ïŒç±³åœãã·ã¬ã³å·ãããã€ãåžïŒã補é ãCode
No.0128â01âïŒã®äžã«åžè²©ããŠããããã«ã³ãž
ãã»ã¢ã«ãã«ã³ã¹ãšã¹ãã©ãã€ãã¢ã®ãã€ã©ã¡ã³
ããšåèèåã®æé·ãä¿é²ããããã«äœ¿çšããã
ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒ
ã«ãªãã·ããŒãŒé µçŽ ãšç¬¬ïŒã®æåäŸãã°ã«ããšãŒ
é žãŸãã¯ããçš®ã®ä»ã®ããšããŒã«ãªãã·ããŒãŒé µ
çŽ åºè³ªãšã®åå¿ã§ã¯ãªããã³ãã«ã¹ã»ããªããªã«
ãã³ã¹ã«ç¹ç°çãªè€è²ã®çè²ãçããã®ã§ãã®åº
質ãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®åå®
å€ãšããŠäœ¿çšãããæ¬çºæã®çèå¹å°ã«äœ¿çšãã
第ïŒã®æåã¯ç²Ÿè£œãµããã³ã§ãããäžè¬ã«ãµãã
ã³ã¯æ€ç©äžã«åºãååžããŠããé ç³äœã§ãæ°Žäžæ²¹
åä¹³æ¿æ¶²ã圢æãããèœåãæã¡ãä¿è·ã³ãã€ã
ãšããŠåããåãµããã³ååã¯ãã®ååã®ã¢ã°ãª
ã³ã³ãæ§æãããµãã²ãã³ãšç³ãšããæããæãŸ
ããçµæãåŸãã«ã¯ç²Ÿè£œãµããã³ã®ã¿ã䜿çšã§ã
ãããšã¯æ³šç®ã«æ€ãããæªç²Ÿè£œãµããã³ãšéã€ãŠ
粟補ãµããã³ã¯åŸ®çç©ç åäœäŸãã°æ¬çºæã®å¹å°
ã䜿ã€ãŠåå®ãè¡ãé µæ¯ã«å¯ŸããŠç¡æ¯ã§ãããäž
è¬ã«1975幎ïŒæ13æ¥ä»ã®åè¡åœç¹èš±ç¬¬3883425å·
ããµããã³ã®ç¡æ¯åãã«çºè¡šãããŠããæ¹æ³ã䜿
çšããŠãµããã³ã粟補ããŠãããã®ç²Ÿè£œãµããã³
ãæ¬çºæã®çèå¹å°ã«äœ¿çšã§ãããæ¬çºæã®çè
å¹å°äžã«ååšãããµããã³ã®å³å¯ãªæ©èœã¯æªç¥ã§
ãããããµããã³ãä¹³åå¹æãæã€ããã«äœæ¶²è©Š
æäžã«ååšãã现èéåããåçè现èãåé¢ã
ããåŸåã瀺ãããšã¯çè«ã¥ããããããã®åé¢
ã«ãã€ãŠããšããŒã«ãªãã·ããŒãŒåºè³ªãšã¯ãªãã
ã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®ããšããŒã«ãªãã·
ããŒãŒé µçŽ ãšã®åå¿ãå©ãããããã®çµæç¹åŸŽç
ãªè€è²ã®çè²ãããè¿ éã«çŸããããã®ãšæãã
ãã æ¬çºæã®çèå¹å°ã«äœ¿çšããããšããŒã«ãªãã·
ããŒãŒåºè³ªã¯ã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³
ã¹ã®ååšäžã§è€è²ã®çè²ãçããããšãç¥ãããŠ
ãããããªãå ¬ç¥ã®åºè³ªããéžæããŠããããé©
åœãªããšããŒã«ãªãã·ããŒãŒåºè³ªã«ã¯ïŒïŒïŒâãž
ããããã·å®æ¯éŠé žãïŒïŒïŒâãžããããã·å®æ¯
éŠé žïŒãããã«ãã¯é žïŒãDOPAãïŒïŒïŒâãžã
ãããã·ã±ã€ç®é žïŒã«ããšãŒé žïŒãã«ããšãŒé žã®
ã¡ãã«ãšã¹ãã«ããã³äºé ¢é žãšã¹ãã«ãïŒâãã
ããã·ããªãã¿ãã³ãïŒïŒïŒâãžããããã·ããš
ãã«ãšã¿ããŒã«ã¢ãã³ïŒãã«ãšããããªã³ïŒãã
ãã³ïŒâããããã·âïŒïŒïŒâãžã¡ããã·ã±ã€ç®
é žãªã©ããããçºè²ã¯ããšãã«ç°ã®ïŒïŒïŒâäœã«
ããæ°Žé žåºã«äŸåãããã®ãšæããããäžèšã®ã
ãšããŒã«ãªãã·ããŒãŒåºè³ªã®ãã¡ã§å¥œãŸããåºè³ª
ã¯ã«ããšãŒé žã§ããã æ¬çºæã®çèå¹å°ã次ã®ããã«ããŠè£œé ã§ã
ãããªãã¯ã¹ãŽãŒã«ã粟補ãµããã³ããã³ããšã
ãŒã«ãªãã·ããŒãŒåºè³ªãé©åœéã®ç²äœæ¯æå€äŸã
ã°å¯å€©ãšãšãã«èžçæ°Žã«æ·»å ãããåŸãããæ··å
ç©ã次ã«ããæ··ããå ç±æ²žéš°ãããŠãããã®æå
ã溶液ã«æº¶è§£ãããã次ã«ãã®æº¶æ¶²ãçŽ121âå§
åçŽ15psiã§çŽ15åéæ» èãããæ» èããŠå°ãå·
åŽããåŸã«éåžžã®åã®ãããªç¿ã«ãã®å¹å°ã泚ã
蟌ã¿ãåºåãããåŸã«ãå¹³æ¿ãè£è¿ãã宀枩ã§ïŒ
æ©ä¹Ÿç¥ããããåŸããããããªç¿ãä¿åã®ããã«
å·èµããããšãã§ããããã¯çŽïŒé±éãŸã§ã®æå¹
æéãæã€ã äžè¬ã«æ¬çºæã®çèå¹å°ã¯æåã«æ·»å ããæ°Žã®
éãåºæºã«ããŠçŽ0.25ãçŽ30ééïŒ ã®ãªãã¯ã¹ãŽ
ãŒã«ãçŽïŒãçŽïŒééïŒ ã®æ¯æå€ãçŽ0.1ãçŽ5.0
ééïŒ ã®ç²Ÿè£œãµããã³ãããã³çŽ0.001ãçŽ1.0é
éïŒ ã®ããšããŒã«ãªãã·ããŒãŒåºè³ªãå«ãã 奜ãŸããã¯äžèšã®æé ã«åŸã也ç¥æåã«æ·»å ã
ãæ°Žã®éãåºæºã«ããŠçŽ0.5ãçŽïŒééïŒ ã®ãªã
ã¯ã¹ãŽãŒã«ãçŽïŒãçŽïŒééïŒ ã®å¯å€©ãçŽ0.1ã
çŽ1.0ééïŒ ã®ç²Ÿè£œãµããã³ããã³çŽ0.005ãçŽ
0.05ééïŒ ã®ã«ããšãŒé žã䜿çšããŠå¹å°ã補é ã§
ãããæã奜ãŸããå¹å°ã¯çŽ1.0ééïŒ ã®ãªãã¯
ã¹ãŽãŒã«ãçŽ2.0ééïŒ ã®å¯å€©ãçŽ0.5ééïŒ ã®ç²Ÿ
補ãµããã³ããã³çŽ0.03ïŒ ã®ã«ããšãŒé žãå«ãå¹
å°ã§ãããæ¬çºæã®çèå¹å°ã®å©ç¹ã®ïŒã€ã¯å šãŠ
ã®æåïŒæ°Žãé€ãïŒãç²äœã§ããããã«äºã秀é
ããåæåãçèå¹å°è£œå€ãšããŠçµåãããŠä¹Ÿç¥
ç¶æ ã®ãŸãŸãã€ãŸã§ã貯èµã§ããå¿ èŠã«å¿ããŠäž
ã«è¿°ã¹ãéåžžã®æé ã«åŸã€ãŠæ°Žãæ·»å ããããšã«
ãã€ãŠå¹å°ã補é ã§ããããšã§ããããšãè¿°ã¹ãŠ
ããå¿ èŠãããã æ¬çºæã®çèå¹å°ãã¯ãªããã³ãã«ã¹ã»ããªã
ãªã«ãã³ã¹ãšã«ã³ãžãã»ã¹ãã©ãã€ãã¢ã®æ¯èŒç
è¿ éãªéå¥åå®ã®ããã®äžæ¬¡å¹é€ãŸãã¯äºæ¬¡å¹é€
å¹å°ãšããŠäœ¿çšã§ãããäžæ¬¡å¹é€å¹å°ãšããŠäœ¿çš
ããå Žåã«ã¯äœæ¶²è©ŠæïŒäŸãã°è¡æ¶²ãåŸæ¶²ãŸãã¯
å°¿ïŒãSOCå¹å°äžã§çŽæ¥å¹³æ¿å¹é€ããçèå¢æ®
ã«é©ããæ¡ä»¶ãæŽããŠãããäºæ¬¡å¹é€æ³ã®å Žåã«
ã¯ãäœæ¶²è©ŠæããŸãäžæ¬¡å¹å°äŸãã°ãµãããŒå¯å€©
ã§å¹³æ¿å¹é€ããããã«ååšããå šçèãããªãè¿
éã«åæå¢æ®ããããã®åæå¢æ®ãèµ·ã€ãŠããã
ã®çèãæ¬çºæã®SOCå¹å°ã®äžã§ç»ç·å¹é€ãã
ããšçš®ã ã®çèçš®ã®éå¥ãéãã«è¡ãããšãã§ã
ãã äŸ ä»¥äžã®äŸã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãã«ã³ãž
ãã»ã¹ãã©ãã€ãã¢ããã³ã¯ãªããã³ãã«ã¹ã»ã
ãªããªã«ãã³ã¹ãå«ããçš®ã ã®çèã®éå¥ã«å¯Ÿã
ãŠæ¬çºæã®çèå¹å°ã®æ¹ãåŸæ¥ã®ãã®ãããæå©
ã§ããããšã蚌æãããã®ã§ããããããã®äŸã¯
æ¬çºæãããããç解ããŠãããããã«ç€ºããã®
ã§ãã€ãŠããã®ç¯å²ãéå®ãããã®ãšè§£éããŠã¯
ãªããªãã äŸ ãã®äŸã¯ã³ãŒã³ããŒã«ã¢ã¬ãŒã«ïŒCMAïŒã
ã«ããšãŒé žããªãã¯ã¹ãŽãŒã«ããã³Tween 80ã
ãæãå¹å°ïŒTOCïŒããã³ç²Ÿè£œãµããã³ããªã
ã¯ã¹ãŽãŒã«ãããã³ã«ããšãŒé žã®æ··åç©ããæã
æ¬çºæã®çèå¹å°ïŒSOCïŒäžã§å¹³æ¿å¹é€ããç
èã®ç¹æ§åœ¢æ å€åãèµ·ãã®ã«èŠããæéãæ¯èŒã
ãããã«è¡ã€ããã®ã§ããã ã¡ãŒã«ãŒã®äœ¿çšèª¬ææžã«åŸãã0.1ïŒ Tween 80
ãè¿œå ããŠCMAã調補ãããTween 80ããªãã¯
ã¹ãŽãŒã«ãã«ããšãŒé žãããã³ãã€ãã¹å¯å€©ãã
æãTOCå¹å°ã次ã®ããã«ããŠèª¿è£œããããªã
ã¯ã¹ãŽãŒã«10ïœãå¯å€©20ïœã10ïŒ Tween 80溶液
10mlãã«ããšãŒé ž0.3ïœãèžçæ°ŽïŒã«å ããã
ãã®æ··åç©ãããæ··ããå ç±æ²žéš°ãããŠãããã®
æåã溶液ã«æº¶è§£ãããçŽ120âã®æž©åºŠçŽ15psiã®
å§åäžã§15åéæ» èãããæ» èãçµãå°ãå·ããŠ
ãããã®å¹å°ããããªç¿ã«æ³šã蟌ãã ãæ¬çºæã®
è©Šéšå¹å°SOCã次ã®ããã«ããŠèª¿è£œããããªã
ã¯ã¹ãŽãŒã«10ïœãå¯å€©20ïœã粟補ãµããã³ïŒïœã
ãã³ã«ããšãŒé ž0.3ïœãèžçæ°Žã«å ããããã®æ··
åç©ãããæ··ããå ç±æ²žéš°ãããŠæåã溶液ã«æº¶
解ããã120âã®æž©åºŠ15psiã®å§åäžã§15åéæ» è
ãããæ» èãçµãå°ãå·ããŠãããã®å¹å°ããã
ãªç¿ã«æ³šã蟌ã¿ãåºåãããã ä¿åé µæ¯æ ªããµãããŒãããŠç³å¯å€©äžã«æ€ç¶ã
ãã72æéå¢æ®ããããäžæ¬¡å¹³æ¿äžã§ã®å¢æ®ãæ¬
ãããã®äºåå¢æ®ã®åŸã«ããã«ã¢âæ³ã«ãã€ãŠç
èãCMAïŒTOCããŸãã¯SOCå¹å°ã®äžã«æ€ç¶ã
ããããã®æ¹æ³ã¯åã«åŸ®çç©ãæ¥çš®ãããé¢ã«ã«
ããŒã°ã©ã¹ã眮ããå¹³æ¿ã®æ¥çš®é¢ãé¡åŸ®é¡ã§èŠ³å¯
ã§ããããã«ããã ãã§ããã倧éã®æ¥çš®ææã
åŸãããã«æ» è綿æ£ã䜿ã€ãŠãµãããŒãããŠç³å¯
倩平æ¿äžã®éèœãéããã CMAïŒTOCãããã³SOCäžã§ã®ã«ã³ãžãã»ã¢
ã«ãã«ã³ã¹ã®åèèåçç£ã«èŠããæéãæ¯èŒã
ãããã«è¡ã€ãè©Šéšã®çµæãè¡šïŒã«ç€ºãã138ã®
匧ç«ããã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãå¹³æ¿å¹é€ããŠ
è¡šïŒã«æèšããæéééã§èŠ³å¯ããã次ã«åå¹å°
ã«ã€ããŠé¡åŸ®é¡ã®100Ãã®èŠéåœãã®çç£ããã
åèèåæ°ãèšé²ãããåå¹å°äžã®åŒ§ç«æ ªã¯å šãŠ
å®è³ªçã«åäžã®ç°å¢ãäžããããã
ãè¡šã
ãè¡šã
è¡šïŒãèŠããšåãããã«ãSOCå¹å°äžã§ã®å
èèåçç£ã¯å ã16æéåŸã«æ倧å€ã«éããŠããŸ
ã€ãããããšå¯Ÿç §çã«ãTOCå¹å°äžã§ã®åèè
åçç£ã¯20æéãããªããã°æ倧ã®æ°Žæºã«éããª
ãã€ããCMAäžã§ã®åèèåçç£ã¯TOCãšSOC
ã®ãããã®å Žåãããèããå£ã€ãŠããã
èèåçç£ã¯å ã16æéåŸã«æ倧å€ã«éããŠããŸ
ã€ãããããšå¯Ÿç §çã«ãTOCå¹å°äžã§ã®åèè
åçç£ã¯20æéãããªããã°æ倧ã®æ°Žæºã«éããª
ãã€ããCMAäžã§ã®åèèåçç£ã¯TOCãšSOC
ã®ãããã®å Žåãããèããå£ã€ãŠããã
ãè¡šã
çºèœç®¡ã®åœ¢æãšåèèåã®çç£ã«åºããæ¬çºæ
ã®SOCå¹å°ã72æéã«ããã€ãŠCMAããã³TOC
ãšæ¯èŒãããïŒçš®é¡ã®ç°ãã«ã³ãžãçš®ãåå¹å°äž
ã§æ¯èŒããããã®è©Šéšã®çµæãè¡šïŒã«ç€ºãã è¡šïŒã®ããŒã¿ã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®çºèœ
管圢æãšåèèåçç£ã®å Žåã«ã¯æããã«SOC
å¹å°ã®æ¹ãTOCå¹å°ãããæå©ã§ããããšã瀺
ããŠããããã®ïŒã€ã®å¹å°ã¯ã©ã¡ããCMAã䜿
ã€ãŠåŸãããçµæãããèããåªããŠããããšã
蚌æããããè¡šïŒã«ç€ºããã«ã³ãžãã»ã¹ãã©ãã€
ãã¢ã«é¢ããããŒã¿ã«é¢ããŠã¯ãSOCãšTOCå¹
å°ã¯å®è³ªçã«åäžã®æ§èœã瀺ããã©ã¡ããCMA
å¹å°ãããèããåªããŠããã æåŸã«ç¹åŸŽçãªè€è²ã®çè²ãã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã«ç¹ç°çãªãã®ãã©ããã
決å®ããããã«ïŒçš®ã®ç°ãçèã®å€æ°ã®æ ªãå¹³æ¿
å¹é€ããããšã«ãã€ãŠSOCå¹å°ã®ã¯ãªããã³ã
ã«ã¹ã»ããªããªã«ãã³ã¹ã«å¯Ÿããç¹ç°æ§ãè©Šéšã
ãã次ã«ç€ºãè¡šïŒããåãããã«ãã¯ãªããã³ã
ã«ã¹ã»ããªããªã«ãã³ã¹ãæ¬çºæã®SOCå¹å°äž
ã§å¹³æ¿å¹é€ãããšå¹³åããŠçŽ5.3æéã§è€è²ã®ç
è²ãçŸããããè©Šéšãè¡ã€ãä»ã®ïŒçš®æ°ã®çèã¯
ã©ãã72æéã®å¢æ®åŸã«ãæ€ç¥ãåŸãçè²ãçã
ãªãã
ã®SOCå¹å°ã72æéã«ããã€ãŠCMAããã³TOC
ãšæ¯èŒãããïŒçš®é¡ã®ç°ãã«ã³ãžãçš®ãåå¹å°äž
ã§æ¯èŒããããã®è©Šéšã®çµæãè¡šïŒã«ç€ºãã è¡šïŒã®ããŒã¿ã¯ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ã®çºèœ
管圢æãšåèèåçç£ã®å Žåã«ã¯æããã«SOC
å¹å°ã®æ¹ãTOCå¹å°ãããæå©ã§ããããšã瀺
ããŠããããã®ïŒã€ã®å¹å°ã¯ã©ã¡ããCMAã䜿
ã€ãŠåŸãããçµæãããèããåªããŠããããšã
蚌æããããè¡šïŒã«ç€ºããã«ã³ãžãã»ã¹ãã©ãã€
ãã¢ã«é¢ããããŒã¿ã«é¢ããŠã¯ãSOCãšTOCå¹
å°ã¯å®è³ªçã«åäžã®æ§èœã瀺ããã©ã¡ããCMA
å¹å°ãããèããåªããŠããã æåŸã«ç¹åŸŽçãªè€è²ã®çè²ãã¯ãªããã³ãã«
ã¹ã»ããªããªã«ãã³ã¹ã«ç¹ç°çãªãã®ãã©ããã
決å®ããããã«ïŒçš®ã®ç°ãçèã®å€æ°ã®æ ªãå¹³æ¿
å¹é€ããããšã«ãã€ãŠSOCå¹å°ã®ã¯ãªããã³ã
ã«ã¹ã»ããªããªã«ãã³ã¹ã«å¯Ÿããç¹ç°æ§ãè©Šéšã
ãã次ã«ç€ºãè¡šïŒããåãããã«ãã¯ãªããã³ã
ã«ã¹ã»ããªããªã«ãã³ã¹ãæ¬çºæã®SOCå¹å°äž
ã§å¹³æ¿å¹é€ãããšå¹³åããŠçŽ5.3æéã§è€è²ã®ç
è²ãçŸããããè©Šéšãè¡ã€ãä»ã®ïŒçš®æ°ã®çèã¯
ã©ãã72æéã®å¢æ®åŸã«ãæ€ç¥ãåŸãçè²ãçã
ãªãã
ãè¡šã
æ¬çºæã®ç²Ÿè£œãµããã³ããªãã¯ã¹ãŽãŒã«ãã«ã
ãšãŒé žå¹å°ãåè¿°ã®Tween 80ããªãã¯ã¹ãŽãŒ
ã«ãã«ããšãŒé žåå¹å°ãšæ¯èŒãããããïŒã€ã®æŽ»
æ§æåã®çžå¯Ÿçå²åãå€ããŠååã®å¹å°ã®è©Šæã
調æŽããã次ã®ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãã«ã³ãž
ãã»ã¹ãã©ãã€ãã¢ãã«ã³ãžãã»ãããã«ãªã¹ã
ã«ã³ãžãã»ã¯ã«ã»ã€ãã¯ãªããã³ãã«ã¹ã»ããªã
ãªã«ãã³ã¹ãããã³ã¯ãªããã³ãã«ã¹ã»ãã€ãã«
ãšã³ã¹ã®å€§æ¥çš®ææãçš®ã ã®è©Šéšå¹å°äžã«ç·æ£ã§
移ããŠå¹³æ¿å¹é€ããïŒããã³24æéåŸã«èŠ³å¯ãè¡
ã€ããã«ã³ãžãèã®å Žåã«ã¯åæ€æ»æã«åœ¢æ å€å
ã芳å¯ããããåŸã€ãŠçºèœç®¡çç£ïŒgtïŒããã€ã©
ã¡ã³ãçç£ïŒïŒŠïŒããã³ãã€ã©ã¡ã³ããšåèèå
çç£ïŒFCïŒã®åœ¢æ å€åã瀺ãåèã®å€ç«æ ªã®å²
åãåå¹å°ã«ã€ããŠèšé²ãããã¯ãªããã³ãã«ã¹
èã®å Žåã«ã¯ç®ã«èŠããçè²ã®å€åã瀺ãå€ç«æ ª
ã®å²åãè©Šéšå€ç«æ ªã®ç·æ°ã«å¯ŸããçŸåçã§èšé²
ããããããã®å Žåã«ã€ããŠïŒããã³24æéåŸã«
çè²ã®æ€æ»ãè¡ã€ãããã®è©Šéšå¹å°ã®æ¯èŒã®çµæ
ã次ã®è¡šïŒã«ç€ºãã
ãšãŒé žå¹å°ãåè¿°ã®Tween 80ããªãã¯ã¹ãŽãŒ
ã«ãã«ããšãŒé žåå¹å°ãšæ¯èŒãããããïŒã€ã®æŽ»
æ§æåã®çžå¯Ÿçå²åãå€ããŠååã®å¹å°ã®è©Šæã
調æŽããã次ã®ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹ãã«ã³ãž
ãã»ã¹ãã©ãã€ãã¢ãã«ã³ãžãã»ãããã«ãªã¹ã
ã«ã³ãžãã»ã¯ã«ã»ã€ãã¯ãªããã³ãã«ã¹ã»ããªã
ãªã«ãã³ã¹ãããã³ã¯ãªããã³ãã«ã¹ã»ãã€ãã«
ãšã³ã¹ã®å€§æ¥çš®ææãçš®ã ã®è©Šéšå¹å°äžã«ç·æ£ã§
移ããŠå¹³æ¿å¹é€ããïŒããã³24æéåŸã«èŠ³å¯ãè¡
ã€ããã«ã³ãžãèã®å Žåã«ã¯åæ€æ»æã«åœ¢æ å€å
ã芳å¯ããããåŸã€ãŠçºèœç®¡çç£ïŒgtïŒããã€ã©
ã¡ã³ãçç£ïŒïŒŠïŒããã³ãã€ã©ã¡ã³ããšåèèå
çç£ïŒFCïŒã®åœ¢æ å€åã瀺ãåèã®å€ç«æ ªã®å²
åãåå¹å°ã«ã€ããŠèšé²ãããã¯ãªããã³ãã«ã¹
èã®å Žåã«ã¯ç®ã«èŠããçè²ã®å€åã瀺ãå€ç«æ ª
ã®å²åãè©Šéšå€ç«æ ªã®ç·æ°ã«å¯ŸããçŸåçã§èšé²
ããããããã®å Žåã«ã€ããŠïŒããã³24æéåŸã«
çè²ã®æ€æ»ãè¡ã€ãããã®è©Šéšå¹å°ã®æ¯èŒã®çµæ
ã次ã®è¡šïŒã«ç€ºãã
ãè¡šã
ãè¡šã
è¡šïŒã®è©ŠæïŒã¯ãªãã¯ã¹ãŽãŒã«âã«ããšãŒé
žå¹
å°ã«Tween 80ãšç²Ÿè£œãµããã³ã®ãããã䜿çšã
ãªãå Žåã®çµæã瀺ãããã®ã§ãããè©ŠæïŒã11
ã§ã¯ã«ããšãŒé žã®éãäžå®ã«ä¿ã¡ããªãã¯ã¹ãŽãŒ
ã«ã®éãïŒè©Šææ¯ã«ïŒïŒè©ŠæïŒãšïŒã®å ŽåïŒãïŒ
ïœïŒïŒè©Šæ10ãš11ã®å ŽåïŒã®ç¯å²ã§å€åãã
ããåäžéã®ãªãã¯ã¹ãŽãŒã«ãå«ãåè©Šæ察ã®ã
ã¡ã®ïŒã€ã¯ãªãã¯ã¹ãŽãŒã«ããã³ã«ããšãŒé žãšçµ
åããŠTween80ã䜿çšããå¹å°ã§ïŒå¶æ°çªå·ã®
è©ŠæïŒãããïŒã€ã¯ä»ååºé¡ããçºæã«åŸã€ãŠç²Ÿ
補ãµããã³ã䜿çšããå¹å°ã§ããïŒå¥æ°çªå·ã®è©Š
æïŒãã©ã¡ãã®å Žåã«ãTween 80ãŸãã¯ç²Ÿè£œãµ
ããã³ã10ïœïŒäœ¿çšãããè©ŠæïŒã11ã®è©Šéšçµ
æã¯ã«ã³ãžãå±ã®åœ¢æ å€åãšã¯ãªããã³ãã«ã¹çš®
ã®çè²å€åã®ããããäžæ¹ãŸãã¯äž¡æ¹ã«å¯ŸããŠæ¬
çºæã®SOCå¹å°ã®æ¹ãTOCå¹å°ãããåªããŠã
ãããšã瀺ããŠããã è©Šæ12ã15ã¯å¹å°ã®ãªãã¯ã¹ãŽãŒã«ãšã«ããšãŒ
é žå«æéãäžå®ã®æ°Žæºã«ä¿ã¡ã粟補ãµããã³å«æ
éãïŒã100ïœïŒã®ç¯å²ã§å€åãããæã«ãã
ãçµæãåŸãããããšã瀺ããŠããããããè©Šæ
12ã15ã®è©ŠéšçµæãããïŒæéåŸã®èŠ³å¯æã«ãã
ãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®çè²é
ã¯ç²Ÿè£œãµããã³ãïŒïœã®ã¿äœ¿çšããæã«æ倧ãšãª
ãããã以äžã®ãµããã³ãæ·»å ããŠãçè²å€åã¯
æ¹åãããªãããšã«æ°ã¥ãã ããã è©Šæ16ã20ã¯çš®ã ã®éã®ã«ããšãŒé žããªãã¯ã¹
ãŽãŒã«ããã³ç²Ÿè£œãµããã³ãšçµåãããŠäœ¿çšã§ã
ãããšã瀺ããŠããããããçŽ0.25ïœïŒä»¥äžã®
ã«ããšãŒé žã§ã¯ïŒæéãŸãã¯24æéã®èŠ³å¯æéã®
éã«æãŸããçè²å€åãåŒèµ·ãããã«ã¯äžååã§
ããããšã«æ³šç®ãã¹ãã§ããã
å°ã«Tween 80ãšç²Ÿè£œãµããã³ã®ãããã䜿çšã
ãªãå Žåã®çµæã瀺ãããã®ã§ãããè©ŠæïŒã11
ã§ã¯ã«ããšãŒé žã®éãäžå®ã«ä¿ã¡ããªãã¯ã¹ãŽãŒ
ã«ã®éãïŒè©Šææ¯ã«ïŒïŒè©ŠæïŒãšïŒã®å ŽåïŒãïŒ
ïœïŒïŒè©Šæ10ãš11ã®å ŽåïŒã®ç¯å²ã§å€åãã
ããåäžéã®ãªãã¯ã¹ãŽãŒã«ãå«ãåè©Šæ察ã®ã
ã¡ã®ïŒã€ã¯ãªãã¯ã¹ãŽãŒã«ããã³ã«ããšãŒé žãšçµ
åããŠTween80ã䜿çšããå¹å°ã§ïŒå¶æ°çªå·ã®
è©ŠæïŒãããïŒã€ã¯ä»ååºé¡ããçºæã«åŸã€ãŠç²Ÿ
補ãµããã³ã䜿çšããå¹å°ã§ããïŒå¥æ°çªå·ã®è©Š
æïŒãã©ã¡ãã®å Žåã«ãTween 80ãŸãã¯ç²Ÿè£œãµ
ããã³ã10ïœïŒäœ¿çšãããè©ŠæïŒã11ã®è©Šéšçµ
æã¯ã«ã³ãžãå±ã®åœ¢æ å€åãšã¯ãªããã³ãã«ã¹çš®
ã®çè²å€åã®ããããäžæ¹ãŸãã¯äž¡æ¹ã«å¯ŸããŠæ¬
çºæã®SOCå¹å°ã®æ¹ãTOCå¹å°ãããåªããŠã
ãããšã瀺ããŠããã è©Šæ12ã15ã¯å¹å°ã®ãªãã¯ã¹ãŽãŒã«ãšã«ããšãŒ
é žå«æéãäžå®ã®æ°Žæºã«ä¿ã¡ã粟補ãµããã³å«æ
éãïŒã100ïœïŒã®ç¯å²ã§å€åãããæã«ãã
ãçµæãåŸãããããšã瀺ããŠããããããè©Šæ
12ã15ã®è©ŠéšçµæãããïŒæéåŸã®èŠ³å¯æã«ãã
ãã¯ãªããã³ãã«ã¹ã»ããªããªã«ãã³ã¹ã®çè²é
ã¯ç²Ÿè£œãµããã³ãïŒïœã®ã¿äœ¿çšããæã«æ倧ãšãª
ãããã以äžã®ãµããã³ãæ·»å ããŠãçè²å€åã¯
æ¹åãããªãããšã«æ°ã¥ãã ããã è©Šæ16ã20ã¯çš®ã ã®éã®ã«ããšãŒé žããªãã¯ã¹
ãŽãŒã«ããã³ç²Ÿè£œãµããã³ãšçµåãããŠäœ¿çšã§ã
ãããšã瀺ããŠããããããçŽ0.25ïœïŒä»¥äžã®
ã«ããšãŒé žã§ã¯ïŒæéãŸãã¯24æéã®èŠ³å¯æéã®
éã«æãŸããçè²å€åãåŒèµ·ãããã«ã¯äžååã§
ããããšã«æ³šç®ãã¹ãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ãªãã¯ã¹ãŽãŒã«ïŒçèæ±ãšãã¹ïŒã粟補ãµã
ãã³ããã³ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåºè³ª
ãæ¯æå€ãšçµåãããŠå«ãçèå¢æ®å¹å°ã ïŒ åèšã®ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåºè³ª
ãšããŠïŒïŒïŒâãžããããã·å®æ¯éŠé žããããã«
ãã¯é žãDOPAãã«ããšãŒé žãã«ããšãŒé žã®ã¡ã
ã«ãšã¹ãã«ãã«ããšãŒé žã®äºé ¢é žãšã¹ãã«ãïŒâ
ããããã·ã«ããªãã¿ãã³ããã«ãšããããªã³ã
ãã³ïŒâããããã·âïŒïŒïŒâãžã¡ããã·ã±ã€ç®
é žããæã矀ããéžãã ãã®ã䜿ã€ããåé ïŒã«
èšèŒã®çèå¢æ®å¹å°ã ïŒ åèšã®ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåºè³ª
ãšããŠã«ããšãŒé žã䜿ã€ããåé ïŒã«èšèŒã®çè
å¢æ®å¹å°ã ïŒ ãªãã¯ã¹ãŽãŒã«ããã³ã«ããšãŒé žãå«ãçè
å¢æ®å¹å°ã«ãããŠãå¹å°ïŒåœã粟補ãµããã³å°
ããšãçŽ0.3ïœãæ·»å ãããåé ïŒã«èšèŒã®çè
å¢æ®å¹å°ã ïŒ å¹å°ã®å«æ°Žéãåºæºã«ããŠçŽïŒãçŽïŒééïŒ
ã®å¯å€©ãçŽ0.1ãçŽ1.0ééïŒ ã®ç²Ÿè£œãµããã³ãçŽ
0.5ãçŽïŒééïŒ ã®ãªãã¯ã¹ãŽãŒã«ããã³çŽ0.005
ãçŽ0.05ééïŒ ã®æ°Žã«æº¶è§£ãããã«ããšãŒé žãå«
ãåé ïŒã«èšèŒã®çèå¢æ®å¹å°ã ïŒ åèšå¯å€©ãçŽïŒééïŒ ãåèšç²Ÿè£œãµããã³ã
çŽ0.5ééïŒ ãåèšãªãã¯ã¹ãŽãŒã«ãçŽïŒééïŒ
ããã³åèšã«ããšãŒé žãçŽ0.03ééïŒ äœ¿ã€ããå
é ïŒã«èšèŒã®çèå¢æ®å¹å°ã ïŒ æ°Žãæ··åããããšã«ãã€ãŠçèå¢æ®å¹å°ã圢
æãããããã®ç²Ÿè£œãµããã³ããªãã¯ã¹ãŽãŒã«ã
ãã³ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåºè³ªãå«ã
也ç¥èª¿åç©ã ïŒ æŽã«æ¯æå€ãå«ãåé ïŒã«èšèŒã®èª¿åç©ã ïŒ åèšæ¯æå€ãšããŠå¯å€©ã䜿ã€ãåé ïŒã«èšèŒ
ã®èª¿åç©ã ïŒïŒ åèšã®ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåº
質ãšããŠã«ããšãŒé žã䜿ã€ããåé ïŒã«èšèŒã®èª¿
åç©ã ïŒïŒ 粟補ãµããã³ããªãã¯ã¹ãŽãŒã«ããã³ããš
ããŒã«ãªãã·ããŒãŒã«å¯Ÿããåºè³ªãæ¯æå€ãšçµå
ãããŠå«ãçèå¢æ®å¹å°äžã§äœæ¶²è©Šæãå¹³æ¿å¹é€
ããããšããæããäœæ¶²è©Šæäžã«ååšããã¯ãªã
ãã³ãã«ã¹ã»ããªããªã«ãã³ã¹ããã³ã«ã³ãžãã»
ã¢ã«ãã«ã³ã¹ã®åå®æ¹æ³ã ïŒïŒ åèšã®ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåº
質ãšããŠã«ããšãŒé žã䜿ã€ããåé ïŒïŒã«èšèŒã®
æ¹æ³ã ïŒïŒ äœæ¶²è©Šæäžã«ååšããã¯ãªããã³ãã«ã¹ã»
ããªããªã«ãã³ã¹ããã³ã«ã³ãžãã»ã¢ã«ãã«ã³ã¹
ã®åå®æ¹æ³ã«ãããŠãåèšäœæ¶²è©Šæãå¢æ®ã®ãã
ã«äžæ¬¡å¹å°ã§å¹³æ¿å¹é€ãããããŠåŸãããå¢æ®ã
ãçèãã粟補ãµããã³ããªãã¯ã¹ãŽãŒã«ããã³
ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåºè³ªãæ¯æå€ãš
çµåãããŠå«ãã§æãäºæ¬¡å¹å°ã§å¹³æ¿å¹é€ããã
ãšããæããåèšåå®æ¹æ³ã ïŒïŒ åèšã®ããšããŒã«ãªãã·ããŒãŒã«å¯Ÿããåº
質ãšããŠã«ããšãŒé žã䜿ã€ããåé ïŒïŒã«èšèŒã®
æ¹æ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/827,573 US4144133A (en) | 1977-08-25 | 1977-08-25 | Fungal growth media |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5437816A JPS5437816A (en) | 1979-03-20 |
| JPS624118B2 true JPS624118B2 (ja) | 1987-01-28 |
Family
ID=25249568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5215478A Granted JPS5437816A (en) | 1977-08-25 | 1978-04-30 | Eumycetes culturing medium |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4144133A (ja) |
| JP (1) | JPS5437816A (ja) |
| AU (1) | AU524139B2 (ja) |
| CA (1) | CA1096758A (ja) |
| CH (1) | CH633314A5 (ja) |
| DE (1) | DE2833846A1 (ja) |
| FR (1) | FR2401222A1 (ja) |
| GB (1) | GB1555449A (ja) |
| IT (1) | IT1102481B (ja) |
| MX (1) | MX5811E (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4882273A (en) * | 1982-12-06 | 1989-11-21 | Nabisco Brands, Inc. | Method of screening microorganisms for the production of extracellular enzymes |
| US4847128A (en) * | 1984-03-22 | 1989-07-11 | Wadley Technologies, Inc. | Miniaturized yeast identification system |
| US5081033A (en) * | 1984-03-22 | 1992-01-14 | Wadley Technologies, Inc. | Miniaturized yeast identification system |
| US4728607A (en) * | 1984-03-22 | 1988-03-01 | J. K. And Susie L. Wadley Research Institute And Blood Bank | Miniaturized yeast identification system |
| US5270032A (en) * | 1990-10-04 | 1993-12-14 | The Research Foundation Of State University Of New York | Composition and method for the prevention and treatment of candidiasis |
| FR2816956B1 (fr) * | 2000-11-17 | 2004-08-20 | Bio Merieux | Procede et milieu de detection/identification de bacteries a activite esterasique |
| US6576457B1 (en) | 2000-12-15 | 2003-06-10 | The United States Of America, As Represented By The Secretary Of Agriculture | Fungal media and methods for continuous propagation of vesicular-arbuscular mycorrhizal (VAM) fungi in root organ culture |
| US20050042711A1 (en) * | 2003-08-11 | 2005-02-24 | George Mason University | Field test for fungi |
| CN101974608B (zh) * | 2010-08-10 | 2013-03-27 | äžæµ·äº€é倧åŠå»åŠé¢éå±æ°åå»é¢ | äžç§èåç§å¹å »åºåå ¶åºçš |
| US20140085085A1 (en) * | 2012-09-26 | 2014-03-27 | Dr. Thomas Paul Cogley | Audio and Light Fungal Growth Indicator |
| CN114214262B (zh) * | 2021-12-27 | 2023-07-21 | æµæ±å€§åŠ | äžç§å¢åŒºæè«æååæéçç©éå¢èœåççé²çèå¢åå¹å »æ¹æ³ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3345270A (en) * | 1964-05-21 | 1967-10-03 | Norwich Pharma Co | Diagnostic composition for isolating and identifying yeasts |
| US3649460A (en) * | 1969-03-07 | 1972-03-14 | Children S Hospital Of The Dis | Isolation of hemophilus bacteria |
| US3870600A (en) * | 1971-03-29 | 1975-03-11 | Kamal Abdou Youssef | Selective and enrichment medium for the isolation identification and propagation of yeasts and fungi |
| US3883425A (en) * | 1973-12-10 | 1975-05-13 | Wadley Res Inst & Blood Bank | Detoxification of saponins |
| US4072572A (en) * | 1976-05-03 | 1978-02-07 | Mcdonnell Douglas Corporation | E. coli detection broth for clinical use with automated microbial analyzer |
-
1977
- 1977-08-25 US US05/827,573 patent/US4144133A/en not_active Expired - Lifetime
-
1978
- 1978-02-23 CA CA297,572A patent/CA1096758A/en not_active Expired
- 1978-03-17 GB GB10698/78A patent/GB1555449A/en not_active Expired
- 1978-03-20 FR FR7808020A patent/FR2401222A1/fr active Granted
- 1978-03-21 AU AU34383/78A patent/AU524139B2/en not_active Expired
- 1978-03-22 CH CH311878A patent/CH633314A5/it not_active IP Right Cessation
- 1978-04-03 IT IT48722/78A patent/IT1102481B/it active
- 1978-04-30 JP JP5215478A patent/JPS5437816A/ja active Granted
- 1978-06-22 MX MX787172U patent/MX5811E/es unknown
- 1978-08-02 DE DE19782833846 patent/DE2833846A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| US4144133A (en) | 1979-03-13 |
| IT7848722A0 (it) | 1978-04-03 |
| DE2833846C2 (ja) | 1987-07-30 |
| GB1555449A (en) | 1979-11-07 |
| DE2833846A1 (de) | 1979-04-05 |
| FR2401222B1 (ja) | 1983-09-09 |
| IT1102481B (it) | 1985-10-07 |
| CH633314A5 (it) | 1982-11-30 |
| JPS5437816A (en) | 1979-03-20 |
| FR2401222A1 (fr) | 1979-03-23 |
| AU524139B2 (en) | 1982-09-02 |
| AU3438378A (en) | 1979-09-27 |
| MX5811E (es) | 1984-07-27 |
| CA1096758A (en) | 1981-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0160743B1 (en) | Miniaturized yeast identification system | |
| PALMER et al. | Diagnostic and therapeutic considerations in Nocardia asteroides infection | |
| JPS624118B2 (ja) | ||
| Odds et al. | Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients. | |
| AU2016382584A1 (en) | Applications of kelimycin in mycobacterium tuberculosis infection resistance | |
| Buffa et al. | Biochemical lesions of respiratory enzymes and configurational changes of mitochondria in vivo: II. Early ultrastructural modifications correlated to the biochemical lesion induced by fluoroacetate | |
| Citron | Specimen collection and transport, anaerobic culture techniques, and identification of anaerobes | |
| Edberg et al. | Esculin-based medium for isolation and identification of Cryptococcus neoformans | |
| Tarshis et al. | BLOOD MEDIA FOR THE CULTIVATION OF MYCOBACTERIUM TUBERCULOSIS VII: Comparison of Blood Agar-Penicillin and Lowenstein-Jensen Media under Routine Diagnostic Conditions | |
| JP7481837B2 (ja) | ã¬ãžãªãã©å±èå¹é€çšã®éæå¹å° | |
| US5081033A (en) | Miniaturized yeast identification system | |
| US4847128A (en) | Miniaturized yeast identification system | |
| Niza et al. | Bacteriological study of the liver in dogs | |
| JP2001128666A (ja) | è¡æ¶²ãŸãã¯ããã³ãå«ãè²çŽ åæ瀺å¹å° | |
| US3597321A (en) | Diagnostic compostion for the differentiation of staphylococci | |
| Fung et al. | Primary culture media for routine urine processing | |
| JP2000500321A (ja) | 奜ãã©ãã£ã³æ§åŸ®çç©ã®æèå€æåæ§ãæ€æ»ããæ¹æ³åã³åšå · | |
| Nobechi | Contributions to the knowledge of Vibrio cholerae I. Fermentation of carbohydrates and polyatomic alcohols by Vibrio cholerae | |
| Adamson | On the cultural characters of certain anaerobic bacteria isolated from war wounds | |
| Taplin et al. | Experience with a new indicator medium (DTM) for the isolation of dermatophyte fungi | |
| KR940000539B1 (ko) | ì íì±ìë ì§ê· ë°°ì§ | |
| Andleigh | Investigations into the role of fungi in Pulmonary Diseases in India | |
| SU1606530A1 (ru) | КÑаЌЌ МОзÑÐžÑ Ð³ÑОбПв РеNIÑILLIUÐŒ ÑÐœRYSПGеNUÐŒ как ÑеÑÑ-кÑлÑÑÑÑа Ўл ОÑпÑÑаМОй алÑЌОМОевÑÑ ÑплавПв Ма гÑОбПÑÑПйкПÑÑÑ | |
| SU1513034A1 (ru) | ÐОÑаÑелÑМа ÑÑеЎа Ўл вÑЎелеМО паÑагеЌПлОÑОÑеÑÐºÐžÑ Ð²ÐžÐ±ÑОПМПв | |
| CN115590866A (zh) | è¯äžçŽ è·ç±»ååç©åšå¶å€ææ°éäžç®ç»èéæ»äº¡è¯ç©äžçåºçš |